SlideShare a Scribd company logo
1 of 52
Download to read offline
٠| P a g e
١| P a g e
٢| P a g e
٣| P a g e
‫آ‬ ‫ا‬‫ا‬
‫ا‬
‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬
benzocaine-1
)‫ر‬(
benzydamine-2
hydrochl
‫ب‬ ‫د‬
cetalkonium-3
‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬
$ %‫وا‬ & !'# ( ) * "+ )
‫ا‬ , - ‫ى‬ ‫ا‬
‫ت‬ & /0# ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬
‫م‬ 2&
‫ث‬ + 4
‫ات‬
" &
/
‫ر‬ ‫و‬
5 0 ‫ا‬ 6 27-
–‫و‬ ( '*
‫ت‬ "# ‫ا‬
"4‫ا‬ 6 ‫ا‬
$ 9
‫ب‬ -‫ا‬.
*< =9& -
‫ل‬ 0?
@2 ‫ا‬ ‫ر‬ '‫آ‬ ‫او‬
9.5
‫ت‬ "9A
‫خ‬
spray
B.B.C
benzocaine-1
)‫ر‬(
clove oil-2
( 07 C ‫ا‬ D &‫ز‬–/
5 F0 ‫وح‬ #
@")
" &
@! 2
5 - ‫ر‬ ‫و‬
‫ن‬ 9%-‫ا‬
1.5
‫ت‬ "9A
5‫ه‬Dentocalm
clove oil-1
(07 C ‫ا‬ D&‫ز‬–‫وح‬ # /
5 F0
geranium-2
" ‫ا‬ & ‫ا‬ & 6)
lidocaine-3
)‫ر‬(
@")
" &
5 - @!2
‫ن‬ 9%-‫ا‬
3.50
‫ت‬ "9A
#I‫ل‬Clovacaine
٤| P a g e
benzocaine-1
)‫ر‬(
( ‫آ‬١٢
K %
(‫ا-آ‬
‫ن‬ 9% ‫ر‬2‫ت‬ "9A5‫ه‬Dentocaine
Jojoba oil-1
( ) * ‫و‬ ‫ت‬ ‫د‬
‫ع‬ 2& ‫و‬ & !' ‫ا‬ @ ‫اع‬ 7-
M, - ‫وح‬ 6 ‫ا‬ ‫م‬ N ‫إ‬ P ,
F/# 7‫أ‬ P ‫إ‬
lidocaine-2
)‫ر‬(
@")
" &
‫ر‬ ‫و‬ /
5 0 ‫ا‬ 6 27-–
‫ج‬
‫ت‬ ‫ا‬
‫ا‬
‫ت‬ ‫آ‬ ‫ا‬
‫ا‬
5
‫ت‬ "9A
gelJogel
aminacrine-1
(used as a topical
antiseptic)
lidocaine-2
)‫ر‬(
@")
" &
50# /
‫ر‬ ‫و‬
7‫ت‬ "9AgelMedijel
cetalkonium-1
‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬
‫ى‬ ‫ا‬ $%‫وا‬ & !'# () * "+ )
‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫ا‬ , -
‫ت‬ & /0#
(‫آ‬ K A
١٢K %
R *
627
50# / ‫و‬
6‫ت‬ "9A(AMundisal
٦| P a g e
anthraquinone-1
glycoside
‫وب‬ !" ‫ا‬ #K C&
50 ‫ا‬ 4 C T2 ‫ا‬
lidocaine-2
)‫ر‬(
salicylic acid-3
‫ب‬ ) ‫د‬ ‫و‬ 5 @!2
٣‫ات‬
" &
$% ! #
‫وح‬ "" ‫"%ج‬" ‫و‬
‫ا‬
5‫ت‬ "9A‫ن‬ ‫ده‬Salivex-l
anthraquinone-1
glycoside
T2 ‫ا‬ ‫وب‬ !" ‫ا‬ #K C&
4 C50 ‫ا‬
menthole-2
M I_‫را‬ ‫ر‬ "? D &‫ز‬
F 0 ‫ة‬Z " M & /K
‫-ت‬ 4‫ن‬ C 4-‫ا‬ (`.
salicylic acid-3
‫ب‬ ) ‫د‬ ‫و‬ 5 @!2
@")
" &
$% ! #
‫وح‬ ‫%ج‬ ‫و‬
‫ا‬
5‫ت‬ "9A‫ن‬ ‫ده‬piravex
lidocaine-1
)‫ر‬(
aminoacridine-2
(used clinically as a
)antiseptictopical
salicylic acid-3
@!2‫د‬ ‫و‬ 5‫ب‬
@")
" &
$% ! #
‫وح‬ ‫%ج‬ ‫و‬
‫ا‬
7.5
‫ت‬ "9A
gelSeptogel
٧| P a g e
lidocaine-1
)‫ر‬(
cetyl pyredinium-2
chloride
thatantisepticIt is an
kills bacteria and other
microorganisms
Chloroceresol-3
‫دة‬ ‫آ‬ ‫دة‬ ‫ا‬ ‫ه‬ ‫#"م‬ $
‫ات‬ %& $ ‫ا‬ '( ‫ذاذات‬ *
' +, ‫ا‬ - " ‫ا‬
@")
" &
),-
‫ر‬ .-‫و‬
4.5
‫ت‬ "9A
gelcanyon
Active Ingredients
Amlexanox...............2
mg
(anti-inflammatory
antiallergic
immunomodulator used
to treat recurrent
aphthous ulcers (canker
sores),)
Inactive Ingredients
Microcrystalline
cellulose, Carbomer,
(‫آ‬ K A
١٢K %
(‫ا-آ‬
‫م‬ 2&
‫ح‬ * ‫ج‬
5 0 ‫ا‬
P #
@ @"c ' ‫ا‬
‫ا‬١٢
`‫آ‬d , M9 %
‫م‬ 2& -‫و‬
( *‫أ‬ ‫ل‬ 0?e
@١٢M9 %
P # ‫أو‬
M K 9 ‫ذوى‬
M" "'? "g
40‫ت‬ "9A‫اص‬ *‫ا‬Alpthtabn
lidocaine-1
)‫ر‬(
jojoba oil-2
*It possesses microbial
properties which
discourage the growth
of bacteria and fungal
microbes
*The oil also contains
nutrients such as
vitamin E, B complex
vitamins, and minerals
such as silicon,
@")
" &
50# /
‫ر‬ ‫و‬
5‫ت‬ "9AgelJobadel
٨| P a g e
1-menthol
‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ !
F "0 5 26 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
2- thymol
= ‫ا‬ @ ‫ج‬ 2) j‫د‬
‫د‬ ‫وه‬ / ‫آ‬ ‫م‬ 2)‫و‬
‫ت‬ & /0#
3-sodium fluride
(Fluoride has been
found to be helpful in
reducing the number of
cavities in the teeth)
Saccharine sodium-4
, #I ‫ا‬ "6 ‫ا‬ 5 / ‫ا‬ , -
50 ‫ا‬
5- Glycerin +
Deionized water.
50# T?
@")
" &
*""" """),-
! """""""""""""""""#‫و‬
$%.
*‫رب‬ """"""""""""""12
3‫ا‬ """"""""""""""" ‫ا‬
4""""" 5 6""""" ‫ا‬
""""" ‫ا‬ """""17‫را‬
""""""""""""""""""""""""" 8
‫ب‬ """"""""""""8 ‫ا‬
) 9.
*‫رب‬ """"""""""""""12
""""""""""""""""" 5
‫"4%ك‬"""""""""""""""""""" ‫ا‬
6""" """ ‫وا‬
‫ن‬ ‫ا‬.
*6"" <9 ""12
‫ظ‬ """ !‫و‬ """9 >$
‫ن‬ ‫ا‬.
9.75
‫ت‬ "9A
orovex
chlorhexidine-1
100mHCL125mg
used in disinfectants
and Active substance
in healing wound
9K
‫وم‬Z# ‫ا‬
‫ث‬ + 4
‫ات‬
" &
),-
! #‫و‬
$%
3‫ت‬ "9AHexitol
٩| P a g e
cetrimide25%-1
?‫د‬ -‫ا‬ ), ‫م‬ . 5 ? ),-
‫ال‬ B-fungs‫و‬microbs
lidocaine-2
)6 D -‫ر‬ .-(
3-sodium fluride
(Fluoride has been found
to be helpful in reducing
the number of cavities in
the teeth)
‫ث‬ +
‫ات‬
" &
*""" """),-
! """""""""""""""""#‫و‬
$%
*"""""" ‫ا‬ """"""
‫ن‬ ‫وا‬
1.30
‫ت‬ "9A
Citrolin-F
1-Povidone iodine
200mg
‫ة‬ """ - ،‫ة‬ """),- G""" 9 ‫ذات‬ ‫دة‬ """-
G"" , ‫ا‬ ‫وق‬ ""1 ‫وا‬ ‫وح‬ "" ‫ا‬ "
G" ‫و‬K" ‫ا‬ G"2 ‫ا‬ ‫ت‬ "! ) ‫ا‬
3‫ا‬ """"""" ‫ا‬ )44""""""" 5)"""""""2 L4 ‫ا‬(
‫ت‬ 2 , ‫وا‬
K A
j 4‫وا‬
" &
*<=9& -
‫ا‬ %
‫ء‬ 9+‫ا‬
( I ‫ا‬
‫ب‬ ) ‫ا‬ ‫%ج‬
‫ا‬ ‫وى‬ ‫و‬
3.20
‫ت‬ "9A
Betadine Mw
1-menthol
‫ع‬ 9 9 ‫ا‬ D &‫ز‬ @ % %‫ا‬ ‫ن‬ !
F "0 5 26 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
clove oil-2
(07 C ‫ا‬ D&‫ز‬–‫وح‬ # /
‫د‬ ‫و‬ 5 F0
3-thymol
‫م‬ 2)‫و‬ = ‫ا‬ @ ‫ج‬ 2) j‫د‬
‫آ‬‫ت‬ & /0# ‫د‬ ‫وه‬ /
4-glycrein
50# T?
@")
" &
$% ! #
‫"%ج‬""""""""""""""""" ‫و‬
"" ‫ا‬ ‫وح‬ ""
""" N """),-‫و‬
$%.
3.75
‫ت‬ "9A
Oracin
١٠| P a g e
1-menthol
‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ !
F"0 526 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
2-methyl salisylate
0.06%
3-eucalyptol
eucalyptol is used in
flavorings, fragrances,
and cosmetics
3-sodium fluride
(Fluoride has been found
to be helpful in reducing
the number of cavities in
the TEETH)
@")
" &
""""" """""),-
! """""""""""""""""#‫و‬
$%
4.90
‫ت‬ "9A
oradent
1-menthol
‫ع‬ " ‫ا‬ O"2‫ز‬ B"- 6" ‫ا‬ ‫ن‬ L-
Q"""" . """" ‫ا‬ 6"""" R""""D 2
‫ن‬ ‫ا‬
clove oil-2
S"" $ ‫ا‬ O""2‫ز‬–‫وح‬ "". ""),-
K3‫ا‬ ‫د‬ +-‫و‬ % Q .-
3-cinnamon
‫ت‬ """! ) ‫ا‬ """19 L- 6"""9 """ 5
2 L4 ‫وا‬ 2 , ‫ا‬
4-methyl paraben
*an anti-fungal agent
often used in a variety
of cosmetics and
personal-care
products.
*It is also used as a
food preservative
" & j),-
! #‫و‬
$%
4.25
‫ت‬ "9A
Ora-zed
١١| P a g e
1-BENZYDAMINE
0.15%
is a locally-acting
nonsteroidal anti-
inflammatory drug with
local anaesthetic and
analgesic properties for
pain relief and anti-
inflammatory treatment
of inflammatory
conditions of the mouth
9K
‫وم‬Z# ‫ا‬
4٣
‫ات‬
),-
! #‫و‬
$%
2.5
‫ت‬ "9A
TANTUM
VERDE
HEXETIDINE 0.1%
IT Is an anti-bacterial
and anti-fungal agent
commonly used in both
veterinary and human
medicine. It is a local
anesthetic, astringent
and deodorant and has
antiplaque effects.[
(‫آ‬١٢
K %
50# /
R *‫و‬
627
5‫ت‬ "9AORALDENE
1-CHLOHEXIDINE
used in disinfectants
2- Sodium citrate
used as an acidity
regulator in drinks
3- sodium borate
used in biochemical and
chemical laboratories to
make buffers
@")
" &
50# /
R *‫و‬
627
14.75
‫ت‬ "9A
LYSOPLAC
١٢| P a g e
S """""""" 2‫ود‬ ‫ا‬ """""""" -‫و‬ !
S""""""""""" U - 67 """"""""""" 3)٢
S""""""""""" 3‫إ‬ 6""""""""""" ‫آ‬ 9(
‫م‬ """"" $ -‫أ‬= )""""" -‫و‬ !
B -‫و‬ """"""""""""""""""""""""""""""""" ‫ا‬((((
، ‫ل‬ """"" - ، ‫ل‬ 4 """""‫آ‬ 2
S"""""#Z! ، ‫ى‬ """"" U2‫إ‬ O"""""2‫ز‬
G""""" L - ‫ت‬ """"" ‫آ‬....
‫ص‬ """""# S""""" ‫اغ‬ """""]
‫1%ب‬ """"""""""""""""""""""""""""""" ^....
‫اص‬ """""""#‫أ‬‫1%ب‬ """"""" ^
""")!٠`٥""" -‫و‬ ! """ -
6"""""""""" 2 B -‫و‬ """""""""" ‫ا‬
B -‫و‬ """""""" ‫ا‬ """""""" -‫و‬ !
‫ت‬ """4‫آ‬ - G""" - 6""" ‫إ‬
G""""""" ! ‫ا‬ ‫م‬ """"""" $ -b‫ا‬
G ‫ا‬ G 2 c....
G ‫ا‬
*1 2 ‫ادورال‬ !
6c . ‫ا‬ ‫ء‬ de ‫ا‬
‫ا‬ N.Q , c ‫و‬
+2‫أ‬ ‫ل‬ cb‫ا‬ 1 2....
67 # ‫ا‬ ‫ام‬ . ^
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
، - 2 ‫ات‬ -‫اب‬i2
‫ا‬ 69 j,4!....
‫ت‬ 1 ‫ا‬ 69 ‫ام‬ . ^
% 9 ‫وى‬ ! G! k ‫ا‬::::
*‫وا‬ ‫ص‬ # 1 2
B 6 ‫إ‬ G S‫آ‬
)6k#‫أ‬ 1!٨‫اص‬ #‫أ‬
‫م‬ ‫ا‬ 69 ‫1%ب‬ ^((((....
m 1 ‫وا‬ ),-
‫م‬ . 2 ‫أ‬ 2 n ‫ذ‬ R-‫و‬
‫ر‬ )d ‫ا‬ ‫ء‬ 3‫أ‬ ‫ادورال‬ !
‫إ‬ S 1 ‫ا‬ B- 6 ‫و‬b‫ا‬ G3%U ‫ا‬
G2 )# ‫ب‬ 4 b....
) N3.75‫اص‬ #‫أ‬
14TABS
‫1%ب‬ ‫ا‬
BradoralBradoralBradoralBradoral
1-lysozym
10mg
2-dequalinium
25mg
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
‫اب‬i2 ، - 2 ‫ات‬ -
‫ا‬ 69 j,4!
m 1 ‫وا‬ ),-) N‫ت‬ 9‫اص‬ #‫أ‬
20TABS
‫1%ب‬ ‫ا‬
laryprolaryprolaryprolarypro
١٣| P a g e
1-dichlorobenzyl
alchol
,antisepticmild
able to kill
andbacteria
associatedviruses
with mouth and
.infectionsthroat
2-amylmetacresol
antiseptican
used to treat
ofinfections
mouththe
throatand
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
2 ‫ات‬ -‫اب‬i2 ، -
‫ا‬ 69 j,4!
‫ب‬ """"""""""") o ‫ول‬b‫ا‬ S"""""""""""
‫ة‬ 1 ‫وا‬ m 1 ‫ا‬
‫ات‬p""""""" ‫ا‬:*‫اص‬ """""""#‫أ‬
""""""""""""""2 L4 ‫دة‬ """"""""""""""+-
‫ة‬ 1 ‫ة‬ ),-
*""""" ),5 6""""" """"" 5
""""""""""""""""> 5‫و‬ Q""""""""""""""""$b‫ا‬
r ‫ا‬
*‫ة‬ """""""""""),- ‫اص‬ """""""""""#‫أ‬
G"""""""""""""" ‫وإزا‬ ‫ة‬ """""""""""""" 1
""""""""""""""""""" ‫ا‬ ‫ب‬ """"""""""""""""""") ‫إ‬
‫ة‬ 1 ‫وا‬
) N‫ت‬ 22‫اص‬ #‫أ‬
20TABS
‫1%ب‬ ‫ا‬
StrepsilsStrepsilsStrepsilsStrepsils
١٤| P a g e
١٥| P a g e
Nicomethanole
hydroflouride
A I ‫ا‬ T24 #K‫ن‬ ‫ا‬ S 511.50‫ت‬ "9AToothpast
e
‫ن‬ 9%‫ا‬ ‫ن‬ 6
‫ن‬ 9%
% 2I ‫ا‬
EGYFLUOR
gel,paste Many
flour
N 1 ‫ا‬ 6‫ن‬ ‫ا‬ S 521‫ت‬ "9AToothpast
e
‫ن‬ 9%‫ا‬ ‫ن‬ 6
‫ن‬ 9 %
% 2I ‫ا‬
Sensodyne
100gm
12‫ت‬ "9A
Sensodyne
55gm
١٦| P a g e
١٧| P a g e
Vit C- 2 ? ‫وا‬ ? -, `# ‫ا‬ Im #K ‫ظ‬ 0I#
`# ‫ا‬ F&Z7 4
@& !) "# K , K 2&
9 ‫ا‬ ‫ء‬ +‫ا‬ ‫ن‬ 9%-‫ا‬
8.00‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
amovit-c
1000
Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C)
‫ن‬ 9%-‫ا‬ @& !) "# K
4.00‫ت‬ "9A‫اص‬ #‫أ‬
20TABSCevarol
500mg
Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C)
‫ن‬ 9%-‫ا‬ @& !) "# K
‫ـ‬
، ‫ا‬ ‫ج‬ ‫إ‬
‫ي‬ ‫ا‬ ‫و‬ ‫وا‬
‫ن‬ !‫ا‬ " #
$ % #&
،‫م‬ %( ‫ا‬ ،$) ‫ا‬ ،‫ن‬ *+,‫ا‬
12.00
‫ت‬ "9A
‫ار‬ 9Vitacid-c1g
١٨| P a g e
١٩| P a g e
chymotrypsin
+ trypsin
‫م‬p$ L ‫ا‬
‫ه‬‫ت‬ 2p$‫ا‬
proteolytic
‫ت‬ 5‫و‬ 4 ‫ا‬ L !
)$‫ا‬ m2 c B
‫ال‬ K 3Z !
exudative
phaseB-
inflamation
- 5 Sk1 49
Speptidic
chainsK !‫و‬
‫ن‬ L ‫ه‬ t 9
inflamation
‫ص‬ #٣- 2 ‫ات‬ -
)G ! S‫آ‬b‫ا‬ S4#(
B-‫و‬‫دة‬ 2‫ز‬ BL ‫ا‬
G 1 ‫ا‬ G ‫ا‬
١-‫ن‬ ‫ا‬ R w !
٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬
٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬
٤-‫ا‬ N ‫اى‬ !
‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9
‫ن‬ ‫ا‬
15‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
Ambezim-g
chymotrypsin
+ trypsin
‫ص‬ #٣- 2 ‫ات‬ -
)G ! S‫آ‬b‫ا‬ S4#(
BL ‫ا‬ B-‫و‬‫دة‬ 2‫ز‬
G 1 ‫ا‬ G ‫ا‬
١-‫ن‬ ‫ا‬ R w !
٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬
٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬
٤-‫ا‬ N ‫اى‬ !
‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9
‫ن‬ ‫ا‬
20‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
Alphintern
٢٠| P a g e
chymotrypsin
+ trypsin
1 ---- 2222- 2 G 4-‫أ‬
B 1 ‫ا‬ m2 c B
6 .5 ‫ان‬ 6 ‫إ‬ 6 + ‫ا‬
G D ‫ا‬ ‫اض‬ b‫ا‬....
••••‫ت‬ 1 ‫ا‬ 69
G -p ‫ا‬:١-٢6 ‫إ‬
٣4 ‫أ‬ ‫ات‬ -....
‫ت‬ 69 G- G k!
# ‫ى‬i ‫ا‬ 6 D ‫ا‬ ‫رم‬ ‫ا‬
G ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ 6 2
18‫ت‬ "9A5‫او‬ B
‫ت‬ 4-‫ا‬
Alpha
Chymotrypsin
1-THIOTEX
ACID 300MG
o" ‫آ‬ "` R 4
١_B2 L5 p 12
)S-k ‫ا‬ B2 L5(
S ] 5 B- B 12 n i
‫ب‬ k ‫ا‬
2-B- B 12
B $ ‫ا‬ B2 L5
B2 L5 m2 c
R ‫ا‬
‫%و‬)‫اوآ‬
B N‫و‬(
DOSE : in severe
cases 300-600 mg.
- by iv. Injection
daily for two to
four weeks, after
that oral tablets
should be used as
300 mg daily as a
maintenance dose.
*I ‫ا‬ , ‫اص‬ *-‫ا‬
j 4‫وا‬ j &‫د‬ ‫ا‬
‫ر‬ /0 ‫ا‬
pC, ‫ب‬ =K-‫ا‬ ‫ب‬ ‫ا‬26‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
THIOTEX
300MG
30‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
THIOTEX
600MG
٢١| P a g e
٢٢| P a g e
‫آ‬ ‫ا‬‫ا‬ ‫ا‬‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬
1-metronidazol
& !'# ‫دة‬
M"_‫ا‬ ‫ه‬ ‫ا‬
*One of the
antibiotic that
kill bacteria by
in hibition of
nuclic acid OF
BACTERIA
30*" ‫آ‬ S"L -
S""""""" , ‫ا‬ ‫وزن‬ B""""""-
*K"""" !S"""" c """"
"""$‫وز‬ G """ ? """
١٠"""""42 5 """"" ‫آ‬.
*K""""""""""""""""""""""" 42٣٠
K""""9 G!‫و‬ """"+-١٠
‫وي‬ "" 2٣٠٠"" -
"""""""""""""""""""""""""""""""""" - 2.
*‫اب‬ """"d ‫ا‬ p"""" ‫آ‬ 5‫و‬
١٢٥S""""L """" -٥
S"""""""""""""""""""""""""""""""""""""""-:
*S"‫آ‬ ‫أذا‬5"! K" -
٥"""""""""""""""""""""""""""""""" -
‫ازول‬ """"""""""""" $‫و‬ -.
*‫م‬ . """""""" 2 ‫أذا‬١٢
B""""""- """""" - 2 S""""""-
S"""""""""""""""""""""""""""""" N%9.
*‫أي‬٤S-٣‫ات‬ -
- 2
*‫ن‬ 9%-‫ا‬ ‫وي‬ K)‫أذا‬
& !' ‫وي‬ K D7 ‫آ‬
M"_‫ا‬ ‫-ه‬(
*M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬
& !' ‫ا‬ T'2
M"_‫ا‬ ‫ه‬ ‫ا‬.
6‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flagyl 500mg
.505
‫ت‬ "9A‫اص‬ *‫أ‬
20
TABS
Flagyl 250mg
04.5
‫ت‬ "9A
‫اب‬ rFlagyl 125mg
*U07
T"‫آ‬ ‫ا‬
F 2 ‫ا‬
K 6 ‫ا‬ U07
) C 2 ‫ا‬
*‫وي‬ K‫ن‬ 9%-‫ا‬)‫أذا‬
& !' ‫وي‬ K D7 ‫آ‬
M"_‫ا‬ ‫-ه‬(
*M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬
& !' ‫ا‬ T'2
M"_‫ا‬ ‫ه‬ ‫ا‬.
2.90"9A‫اص‬ *‫أ‬
20
Flagicure forte
500mg
1.60
"9A
‫اص‬ *‫أ‬
20
TABS
Flagicure 250mg
٢٣| P a g e
1-amoxycillin
2-flucloxacillin
‫ن‬ & "4 ‫دان‬ ‫ه‬
‫ا‬s‫وه‬"#K , p"# ‫ا‬
‫ج‬ K , " K
‫ت‬ ‫و‬ !" ‫وى‬ ‫ا‬
' 2 ‫وا‬ 'A ‫ا‬
‫ام‬ 6 ‫ا‬ c'= ‫ا‬.
*@"##"% 2‫آ‬ #‫آ‬ #0 ‫ا‬
flucloxacillin)(
‫ى‬ * "+ )
j‫ز‬ 0 ‫ا‬ ‫ت‬ ‫و‬ !" ‫ا‬
5&Z7-Z"9"##"29
penicillinase
*‫ل‬ 0? ‫و‬ ‫ر‬ '!#
‫ق‬ ,١٨K
2'‫آ‬500mg
(‫آ‬٦-٨‫او‬ ‫ت‬ K %
‫ص‬ *1g(‫آ‬١٢
j r T24 K %
‫وى‬ ‫ا‬
*4 ‫ل‬ 0?-‫ا‬١٠
‫ات‬ 9%١٢٥56-
٢٥٠(‫آ‬ (٨
‫ت‬ K %
*‫ن‬ 9%-‫ا‬ ‫وي‬ K
50 ‫وا‬)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*‫وح‬ 6 ‫ا‬ ‫ث‬ #)
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
7.5
‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flumox 250 mg
18‫ت‬ "9A
20
TABS
‫اص‬ *‫ا‬
Flumox 500 mg
24‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flumox 1G
13‫ت‬ "9A‫اب‬ rFlumox 100 (
T"‫آ‬ ‫ا‬ U07K 6 ‫ا‬ U07*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬
)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*‫وح‬ 6 ‫ا‬ ‫ث‬ #)
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
6‫ت‬ ) NFlumox 1G
٢٤| P a g e
@"##"2"2‫آ‬ ‫أ‬
"%‫أ‬ o"9" ", ‫.وآ‬
@ @"##"2"2‫آ‬ v‫ا‬
7‫أ‬ ‫وف‬ ‫ا‬
‫ت‬ 6 ‫ض‬ &
‫ن‬ !, ‫م‬ ‫-آ‬ "' ‫ا‬
‫د‬ A‫و‬ ‫وي‬ ‫ا‬ @
‫دة‬‫ر‬ C) M ,
‫ع‬ 9 ‫ا‬ ‫ا‬s‫ه‬ 4‫د‬ P#K
‫وم‬ C ‫ا‬ & !' ‫ا‬ @
j‫ود‬ @"##29'#
‫ن‬ !"‫ه‬
"%‫أ‬ o"9" ", ! ‫.ا‬
Clavulinic acid
‫ر‬ 4L ‫اص‬ #b‫:ا‬
625 ١٠٠٠(‫آ‬ 56
١٢‫ة‬ MK %٧‫م‬ &‫أ‬
M# ‫آ‬
*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬
)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*6 ‫ا‬ ‫ث‬ #)‫وح‬
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
58‫ت‬ "9A‫اص‬ *‫أ‬
14TAB
S
Augmentin1g
35‫ت‬ "9A‫اص‬ *‫أ‬
10TAB
S
Augmentin625
mg
375‫ت‬ "9A‫اص‬ *‫أ‬
10TAB
S
Augmentin375
mg
11.5‫ت‬ "9A9C4
Augmentin600
mg
T"‫آ‬ ‫ا‬ U07‫ل‬ c{ ‫اب‬ d ‫ا‬:
B-١-٦‫ات‬:
50*@ 56
Z"‫آ‬ )@"##2"2‫آ‬ -‫ا‬
P#K M 2C 56‫آ‬ (!
M+ + ‫أو‬ @" K A.
*7‫وز‬ (0? P9
١٢y & 56‫آ‬٤(
Z"‫آ‬ ) @٣١٢M+ +
" & ‫ات‬.
B- K ‫أ‬٦‫ات‬:
5*‫ات‬ M+ + (
Z"‫آ‬ ) @ " &
٤٥٧
‫ام‬ %-‫ا‬ U0728‫ت‬ "9A‫اب‬ r
Augmentin312
mg/5ml
37‫ت‬ "9A‫اب‬ r
Augmentin457
mg/5ml
٢٥| P a g e
T"‫آ‬ ) U07
‫ال‬
Augmenti
n
‫ر‬ '!# ‫اص‬ *v‫*ا‬
625 mg (‫آ‬١٢j٧‫م‬ &‫ا‬
*(‫آ‬ ‫او‬١٢K %١‫ام‬ A
j & z ‫ا‬ ‫وى‬ ‫ا‬ 4 ,
‫ب‬
*‫ن‬ 9%-‫ا‬ ‫وي‬ K
50 ‫وا‬)& !' ‫ا‬
‫ام‬ 6 ‫ا‬ 'A
‫ام‬ 6 ‫ا‬ ' %‫و‬
& !' ‫وا‬
"_‫ا‬ ‫ه‬ ‫ا‬(
*‫ث‬ #)‫وح‬ 6 ‫ا‬
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
*6) 9 ‫ا‬ ‫ت‬ -‫ا‬
& !' ‫ا‬ @K)T ‫ا‬
`# ‫ا‬(
25‫ت‬ "9A‫اص‬ *‫أ‬
8 TABS
Hibiotic 1g
26‫ت‬ "9A‫اص‬ *‫أ‬
10 TABS
Hibiotic 625mg
19‫ت‬ "9A‫اص‬ *‫أ‬
10 TABS
Hibiotic 375mg
U07
T"‫آ‬ ‫ا‬
B-١-٦‫ات‬
50@ 56Z"‫آ‬ )
56‫آ‬ (! @"##2"2‫آ‬ -‫ا‬
‫أو‬ @" K A P#K M 2C
M+ +.
7‫وز‬ (0? P9١٢56‫آ‬
y &٤Z"‫آ‬ ) @ (٣٢٠
٣" & ‫ات‬
B- K ‫أ‬٦‫ات‬:
5(٣@ " & ‫ات‬
Z"‫آ‬ )٤٦٠.
@ '‫أآ‬ (0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫اذا‬
٤٠‫ر‬ '! ‫ا‬ MK A syd& 56‫آ‬
‫ام‬ %-‫ا‬ U07‫ت‬ "9A23‫اب‬ rHibiotic 460mg
‫ت‬ "9A32‫اب‬ rHibiotic 460mg
٢٦| P a g e
‫ز‬p1- ‫ص‬ # S‫آ‬
6 ‫ى‬ 12
B ‫آ‬ -‫أ‬
‫رات‬ ‫ه‬ ‫اى‬ 5
‫آ‬ ‫آ‬ 9‫و‬
‫م‬ 2‫د‬ ] B
‫رات‬ ‫ه‬ $ -
‫دل‬ 2:
-B ‫آ‬ -‫أ‬
500-
‫آ‬ ‫آ‬ 9
B2500-
B e 4 ‫ا‬
*(‫آ‬ ‫ص‬ *٨@! &‫و‬ ‫ت‬ K %
(‫آ‬ / & ‫ان‬٦, ‫ت‬ K %
j & z ‫ا‬ m-‫ا‬ 4
B B- ‫ل‬ c% ‫ا‬
١٦-٨
*(‫آ‬ ‫ص‬ * F=7 / &٨
/ & ‫ان‬ @! &‫و‬ ‫ت‬ K %
(‫آ‬ ‫ص‬ * F=7٦‫ت‬ K %
`‫ا-آ‬ m-‫ا‬ 4 ,
j‫ر‬ /y
١-‫ن‬ ‫ا‬ ‫اج‬ w
٢-U ‫ا‬ ‫ب‬ ) ‫ا‬
٣-‫وى‬ ‫ا‬
2 L4 ‫ا‬
‫ت‬ "9A 20‫اص‬ *‫أ‬
10 TABSFloxamo
1 M"#K , 5A
"2‫دروآ‬ 0"%
‫ل‬
‫ج‬ ‫دة‬ ‫ا‬ MK 6 ‫ا‬
‫ب‬ ‫ا‬50 ‫ا‬ 627‫وا‬ ‫ن‬ 9%-‫وا‬
‫ه‬١‫ة‬ 4‫وا‬ MK 6‫آ‬ ‫ام‬ A
#K M 2C ‫او‬ ‫م‬ " ‫ا‬ ,
‫ة‬ @" &‫و‬ 2 @" K A١٠
(*-‫ا‬ #K ‫م‬ &‫ا‬
*‫وى‬
‫ن‬ ‫وا‬ ‫ا‬
‫ت‬ "9A 8‫اص‬ *‫أ‬
8 TABS
Curisafe
٢٧| P a g e
Amoxycillin as
250mg, 500mg and
1000mg injections.
‫وى‬ ‫ا‬ 69
2 L4 ‫ا‬
*G 4‫آ‬٥٠٠-
S‫آ‬٨‫ت‬
*B 4‫آ‬٥٠٠
S‫آ‬ -١٢G
2 # ‫ا‬ 69
‫م‬ . 5
*9C4١‫ر‬ '!# ‫ام‬ A
*9C4500‫ام‬ 6
‫ل‬ 0?
(for mor
information
visit this web)
http://www.me
dsafe.govt.nz/pr
ofs/datasheet/i/i
biamoxinj.pdf
*prevent
blood
infection
due to
procedures
such as
dental
extractions
in patients
who are at
risk of
developing
endocarditi
s
*S4# ‫م‬ . 5
‫ن‬ ‫ا‬ R w
B- 2 #
endocarditi
s
6D - 69
6 1 ‫ا‬
-p5 -‫و‬ ‫ا‬
& !' ‫ا‬ ‫وى‬ ‫ا‬
*
"9A 3.70‫اص‬ *‫أ‬
12
TABS
IBIAMOX25
0 mg
"9A 8.00‫اص‬ *‫أ‬
12
TABS
IBIAMOX50
0 mg
٢٨| P a g e
٢٩| P a g e
@" `" ‫و‬ ) ‫رو-ك‬ "‫آ‬٣٠
56 Ketorolac
tromethamin
‫م‬p $ L ‫وا‬ ‫اص‬ . ‫:ا‬
‫-ك‬ "‫آ‬MK 6 P ‫إ‬ P 9&
"g ‫ت‬ |‫ا‬ ‫دات‬
M&‫ود‬ " 2 ‫ا‬ NSAIDs o s ‫و‬
P &Z7‫إ‬ p"'`) P#K (" & ,
‫ز‬ 9"6"2‫اوآ‬ #!"%١‫و‬٢
(COX-1+COX-2)
‫ق‬ ?-‫ا‬ P#K ‫اه‬ *‫ا‬ ' &‫.و‬
B 1 ‫ا‬ N
O15 B e 4٦٠-:
‫-ك‬ "‫آ‬@") @C4
P=*‫ا‬ I " &٤
C4‫ة‬ ‫و‬ " & @
‫ي‬ =* ‫ام‬ %‫إ‬٥&‫أ‬‫م‬
‫ال‬ ‫ق‬ 9٦٠-:
‫-ك‬ "‫آ‬ ‫ل‬ ' ‫أ‬ F=7
I " & @")
P=*‫أ‬٤" & @C4
‫ي‬ =* ‫ام‬ %‫إ‬ ‫ة‬ ‫و‬
٥pC, ‫م‬ &‫أ‬
‫ى‬ # BL -
‫ن‬ ‫وا‬ ‫ا‬
"9A 10‫اص‬ *‫أ‬
20
TABS
Ketolac
10 "9A5 @C4Ketolac
‫م‬ 5 ! ‫ك‬ 9 L2‫.د‬
Diclofenac
Potassium
25-50@ 56
(‫آ‬ ‫ص‬ *‫أ‬ ‫م‬ , ‫آ‬٨
‫ت‬ K %.
‫ول‬ ! |k 2‫و‬
! ‫اص‬ #‫أ‬ ‫9%م‬ ‫آ‬
? 3Z ‫ت‬ 4N ‫ا‬
‫ة‬ ‫ا‬ K.
-‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
GU ‫وا‬.
"9A 5‫اص‬ *‫أ‬
10TABCata lam50mg
9"9A‫اص‬ *‫أ‬
10
TABS
Cata lam25mg
‫ي‬ I) M'#K A &
P#K٣‫-ت‬ ' ‫أ‬
P#K ‫ي‬ I) M'#K‫و‬٦
% ‫-ت‬ ' ‫أ‬
9 (‫آ‬ P, M ' -‫ا‬
٤}٧M ' e "9A.
@C4Cataflam75mg
٣٠| P a g e
‫ك‬ 9 L2‫د‬
‫م‬ 5 !.
Diclofenac
Potassium
B e 4 ‫ا‬:
‫أو9%م‬ ‫ل‬ ‫إ‬ 2٥٠
‫اص‬ #‫أ‬٣‫ات‬ -- 2
G2 # ‫ت‬ 4N ‫ا‬ !
‫ة‬ ‫ا‬ K ? 3Z5 B-.
O15 ‫ل‬ c{١٢
-:
‫أو9%م‬ ‫ل‬ ‫إ‬ 2٢٥
Kk#‫ا‬ 1! ‫اص‬ #‫أ‬٣
- 2 ‫ات‬ -.
‫أو9%م‬ ‫ام‬ . ‫أ‬ R 2
‫ل‬ c{ - 5 ‫اص‬ #‫أ‬
O15٩2‫و‬ ‫ات‬
‫ع‬ #‫أ‬ ‫ام‬ . ‫إ‬
B ‫دو‬ ‫أو‬ B2‫ر‬ 9
- !..
-GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬"9A 5.5‫أ‬‫اص‬ *
10TAB
Oflam 50
"9A 3.5
‫اص‬ *‫أ‬
10TAB
Oflam25
‫م‬ "% ) ‫ك‬ 9", #!&‫د‬
– Diclofenac
Potassium.
B e 4
٧٥-١٥٠, 56
j 4‫وا‬ K 6‫آ‬ ‫م‬ " ‫ا‬
#K 2C ‫او‬
‫ت‬ K A
K @ ‫ل‬ 0?-‫ا‬)١-
١٢(9%١-٣56
#K 2C ‫م‬ " ‫ا‬ ,
‫ت‬ K A
-‫ن‬ 9%-‫ا‬ $#y
-‫-ت‬ 4 ,
‫ح‬ z)‫وا-ر‬ ‫ب‬ -‫ا‬
‫ت‬ "# ‫ا‬ 5 ~ ‫ا‬
M"4‫ا‬ 6 ‫ا‬
6"9A‫اص‬ *‫أ‬
20TAB
Dolphin K25
mg
8"9A‫اص‬ *‫أ‬
20TAB
Dolphin K50
mg
6.5"9A102'‫آ‬Dolphin K75
mg
6.75"9A3@C4Dolphin K75
mg/3m
٣١| P a g e
B 9‫و‬ ! ‫آ‬
Ketoprofen*M 2'‫آ‬٣‫ات‬
(‫ا-آ‬)٥٠•(
*( K M9C4" &
*MC #٣‫ات‬
١-‫ت‬ ‫د‬
٢-‫-م‬ @!2
٣-‫-ت‬ 4 , K 2
F7-‫ا‬ ‫ت‬ ‫ا‬
‫ة‬ 69I ‫وا‬ ‫وا-ذن‬
‫ن‬ 9%-‫ا‬ ‫ب‬ ‫وا‬
1.75 "9A‫اص‬ *‫أ‬
10TAB
Ketolgin
25mg
2 "9A‫اص‬ *‫أ‬
10TAB
Ketolgin50m
g
8 "9A10 2'‫آ‬Ketolgin
200mg
3 "9A3 @C4Ketolgin100
mg
B 9‫و‬ ! ‫آ‬
Ketoprofen
*M 2'‫آ‬٣‫ات‬
(‫ا-آ‬)٥٠•(
*( K M9C4" &
-GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬3.753.753.753.75) N‫اص‬ *‫أ‬
10TAB
Ketofan
25mg
5555‫ت‬ ) N20 2'‫آ‬Ketofan
50mg
5555‫ت‬ ) N10 2'‫آ‬Ketofan
75mg
3333‫ت‬ ) N3@C4Ketofan
100mg
G """"""""""" 4‫آ‬ S"""""""""""‫آ‬
‫ى‬ """" 15 G"""" 5% N
6"""""""""::::
200200200200"""""" -
‫اب‬i- B 9‫و‬ ! 42‫ا‬
1- 2@K M 2'‫آ‬
( ‫آ‬ 5 0 ‫ا‬ S & ?٤-
٦9K ‫أو‬ ‫ت‬ K %
‫وم‬Z# ‫ا‬.
@! 2 @" 0" ‫را‬
‫€-م‬ $& %
‫ل‬ , R, y‫و‬
‫د‬ ‫و‬ ‫ارة‬ I#
‫ت‬ -
3.503.503.503.50) N‫اص‬ *‫أ‬
10TAB
Rapifen200
mg
٣٢| P a g e
1-paracetamol
350mg
2-ibuprofen
200mg
B e 4
‫ات‬ - ‫3%ث‬ ‫ص‬ #
- 2
‫ل‬ c%
‫"%ث‬""3 ‫ص‬ """# Q"""k$
- 2 ‫ات‬ -
GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬2.752.752.752.75) N‫اص‬ *‫أ‬
20TAB
Megafen
ibuprofen-1‫ر‬ """""""""4L:S"""""""""+ 2
""""" ! ?i"""""w‫ا‬‫م‬ """"" , ‫ا‬
6"""" ?‫ر‬ """"3‫ا‬ S""""
G""""""" N‫و‬ ? """"""" ‫ا‬
‫ر‬ """""4L٤٠٠""""" -
‫ت‬ O S‫آ‬
‫ل‬ c%:S+ 2
K‫وه‬ # G N
٢٠٠O S‫آ‬ -
‫ت‬
‫3""""""""%ث‬ ‫اب‬ """"""""€ ‫او‬
- 2 ‫ات‬ -
GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
B L ‫ا‬ Sk - ‫م‬ ‫ا‬
6.756.756.756.75) N‫اص‬ *‫أ‬
20TAB
Brufen200
mg
13.5013.5013.5013.50) N‫اص‬ *‫أ‬
20TAB
Brufen400
mg
15151515) N‫اص‬ *‫أ‬
20TAB
Brufen600
mg
6666) N‫اب‬ rBrufen100
mg /150ml
٣٣| P a g e
‫ك‬ 9 L2‫د‬
‫م‬ 2‫د‬ ]
‫ر‬ """""""4L ‫ا‬:٧٥-١٥٠
‫م‬ " ‫ا‬ P , 5 c#،
‫او‬ ‫ة‬ 4‫وا‬ M K 6
M K‫ز‬ ‫و‬ M 2C
‫م‬ " ‫ا‬ ‫ل‬ y.
‫ل‬ c ‫ا‬:٣(! •#
S& ? @K ‫م‬ " ‫ا‬ P, 56‫آ‬
#K M 2C 50 ‫ا‬٢-٤
ً" & ‫ات‬.
‫ل‬ `:(0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫إذا‬
٣٠/ & 56‫آ‬٦٠‫إ‬
٩٠#K M 2C •#٢-
٤P & ‫ات‬
-‫ل‬ o‫ا‬ 6 ‫دوا‬
-‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
GU ‫وا‬.
11.2511.2511.2511.25) N‫اص‬ *‫أ‬
30TAB
Voltaren 25
11.9011.9011.9011.90) N‫اص‬ *‫أ‬
20TAB
Voltaren 50
28) N‫اص‬ *‫أ‬
10sr TAB
Voltaren-
sr 100
12.75) N3@C4Voltaren 75
Ibuprofen‫ر‬ """4L ‫ا‬:‫واء‬ ‫ا‬ s y‫أ‬
M &‫و‬ y ‫ة‬ P #K
( ,‫أ‬ P / &
‫إن‬ ‫و‬ ‫ص‬ = ‫أ‬
( 0 ‫ا‬ @ ‫ن‬ ‫آ‬
‫م‬ / ‫ا‬ $ js y‫أ‬
‫ر‬ ‫ا‬ j "+d ) ( "#C
‫ة‬ ‫ا‬ P#K.
P / &٤٠٠5 6
D % ‫أو‬ $ ‫أر‬ ( ‫آ‬
‫ت‬ K %.
‫ا‬s ‫ه‬ ‫َم‬ 2ُ&
‫ج‬ ُ‫ء‬‫…وا‬ ‫ا‬
‫ب‬ ‫ا‬( ِm 0 ‫ا‬
B """""""L ‫ا‬ S"""""""k ‫آ‬
""""""" ‫ا‬ Q""""""" . ‫و‬
S] ‫ا‬ K9.
4) N‫اص‬ *‫أ‬
10sr TAB
Ibuprofen
400mg Tabs
٣٤| P a g e
Mefenamic acid٥٠٠‫ام‬ N S-٣
- 2 ‫ات‬ -.
*T4 = ‫ا‬ 5 v‫ا‬
‫ب‬ -‫ا‬ ‫أو‬ ‫رم‬ #
‫ت‬ m|‫ا‬ $ ' & ‫ي‬s ‫ا‬
‫أو‬ M" ‫ا‬
M"4‫ا‬ 6 ‫ا‬.
‫ت‬ ‫إ‬0 ‫ا‬(m
-*‫ارة‬ I# R, y.
5.50) N‫اص‬ *‫أ‬
10 TAB
Mefenam
500mg
Lornicam*@ ‫ص‬ * $ #'&
‫م‬ !"7‫ر‬٨5 6
M & % ‫اص‬ *‫ا‬
" ‫آ‬ $ @ ‫و‬s ‫ا‬
@ ' % 9
(_‫ا‬ 2 ‫ا‬.
*‫ول‬ 9) 5 &
, ‫اص‬ *-‫ا‬
‫ت‬ K A@
٨T 6& -‫و‬ 5 6
I ‫ا‬ / )
‫ح‬ 2 ‫ا‬ =*-‫ا‬
‫ت‬ K 6 ‫ا‬ @
‫وه‬١٦" & 56
p') ‫ا‬ 5 -‫ا‬
‫ب‬‫رج‬ y
( m 0 ‫ا‬‫ج‬ ‫و‬
5 -‫ا‬ ‫اض‬ K‫ا‬
, ‫ب‬ -‫وا‬
‫ب‬ -‫ا‬ ‫-ت‬ 4
Y ‫ا‬
‫ب‬ ‫وا‬ # =0 ‫ا‬
( =0 ‫ا‬
7‫ا‬ + ‫ا‬.
13.00) N‫اص‬ *‫أ‬
10 TAB
Lornicam
Rapid
tablets
٣٥| P a g e
oral
gel
Daktarin
oral
gel
Miconaz 2%
oral
gel
Micoban 2%
- 2 ‫ات‬ - ‫3%ث‬*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
18‫ت‬ "9A
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4,70‫ت‬ "9A
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4,90‫ت‬ "9A
٣٦| P a g e
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
٣٧| P a g e
Nystatin
mechanism
NYSTATIN
bind to sterols in
the fungal cell
membrane...
RESULTING
IN disturbances
in cell
membrane
function as
selective barrier
,THIS LEADS
TO loss of
essential cellular
constituents
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
3.50"9AOral
drops
Nystatin 30 ml
Nystatin
S 2 ‫ا‬ ‫م‬Z7 !" ‫ا‬ U07
.‫آ‬٨‫ت‬ 0/٦
& ‫ا‬ 3$4 ‫ت‬ 0
$ ‫ا‬ ‫او‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4‫ت‬ "9AOral
drops
Fungistatin
30ml
Nystatin
r $‫م‬p$ L ‫ا‬
m! ‫ا‬
.‫آ‬٨‫ت‬ 0/٦
& ‫ا‬ 3$4 ‫ت‬ 0
$ ‫ا‬ ‫او‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4‫ت‬ "9AOral
drops
MYCOSTATI
N 30 ml
٣٨| P a g e
٣٩| P a g e
Calcium
glubionate
1200mg5ml
- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
5‫ت‬ "9A
‫اب‬ rHi-cal 100ml
Calcium- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
5‫ت‬ "9A
‫اب‬ rGolden cal
100ml
Calcium" & j 4‫وا‬ j•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
7.50‫ت‬ "9A‫اب‬ rCalci cal
٤٠| P a g e
Calcium
carbonate
500mg
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
‫ن‬ ‫ا‬2 #
3‫ت‬ "9A12 cap
- 2'‫آ‬
‫ت‬
Calcimate 500
500mg of
calcium
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
2 # ‫ن‬ ‫ا‬
6‫ت‬ "9A‫اص‬ *‫أ‬
10
TAB
Bone-cal
*Calcium
carbonate
=700mg
*calcium 180mg
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
2 # ‫ن‬ ‫ا‬
15‫ت‬ "9A‫اص‬ *‫أ‬
30
TAB
marcal
٤١| P a g e
٤٢| P a g e
Cod liver oil
‫ت‬ I ‫ا‬ '‫آ‬ D&
1cap _ 1-2times
daily
_‫ا‬s g ( !
‫ر‬ = ' &
‫د‬ @" "0
@" ",»‫د‬«
#K K 2&
T" % )
=9K
P , ‫م‬ " 2 ! ‫ا‬
‫م‬ Y ‫ا‬
‫ن‬ 9%v‫وا‬
22‫ت‬ "9A- 2'‫آ‬
‫ت‬
120
cap
Seven seas
Cod liver oil
+vit a.d3.c
1 cap _ 1-
2times daily
U 07
0"‰ ‫ا‬
C 2 ‫ا‬
29‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 cap
Ultranyl
Cod liver oilAdult 1 cap _
1-2times daily
U 07
0"‰ ‫ا‬
C 2 ‫ا‬
28‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 capCod liver oil
٤٣| P a g e
Cod liver oil
100mg
Adult 1cap _ 1-
2times daily
_‫ا‬s g ( !
‫ر‬ = ' &
‫د‬ @" "0
@" ",»‫د‬«
#K K 2&
T" % )
=9K
P , ‫م‬ " 2 ! ‫ا‬
‫م‬ Y ‫ا‬
‫ن‬ 9%v‫وا‬
14,90‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 cap
Fort sea
vitA,c,d,omega
3,EPA.DHA
2.5:5ml.2-3
times daily
according to
kids edge
0"‰ ‫ا‬ U 07
C 2 ‫ا‬
14,90‫ت‬ "9A120ml.
‫اب‬ r
High sea 120ml
Vit.A4600i.u
Vit D380i.u
C52mg
2.5:5ml.2-3
times daily
according to
kids edge
0"‰ ‫ا‬ U 07
C 2 ‫ا‬
13,90‫ت‬ "9A120ml
‫اب‬ r
Halorang 120ml
٤٤| P a g e
٤٥| P a g e
Lidocaine hcl
40mg
MK 6:
‫"%ج‬"""""""""" 6"""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
8‫ت‬ "9ASPRA
Y
‫خ‬
LIDO SPRAY
Lidocaine 10%MK 6:
6"""""""""""9‫"%ج‬""""""""""
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
١٠‫ت‬ "9ASPRA
Y
‫خ‬
Lidocaine
SPRAY
Lidocaine 5%MK A:
‫"%ج‬"""""""""" 6"""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
2.40‫ت‬ "9A5‫ه‬LIDOSINE
٤٦| P a g e
Lidocaine 2%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
S 2 ‫ا‬ U073‫ت‬ "9AGelLIGNOCAINE
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
‫ن‬ 9 %-‫ا‬( '* ‫او‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
10‫ت‬ "9ASPRA
Y
‫خ‬
LIGNOCAINE
٤٧| P a g e
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
Š# ‫ا‬@
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
10‫ت‬ "9ASPRA
Y
‫خ‬
LIGNORAL
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
44.75‫ت‬ "9ASPRA
Y
‫خ‬
Xylocaine
٤٨| P a g e
٤٩| P a g e
Hydrocortisone
‫ات‬ &‫و‬ 2 ‫ا‬ @ ‫ه‬
( & ‫وه‬ & zC ‫ا‬
$9 ‫او‬ R0y #K
6 %-‫ا‬ @ & ‫ا‬
S& ? @K ‫ت‬
‫ز‬ 6 ‫ا‬ , "c ‫ا‬
K 9 ‫ا‬
" & @"), !I ‫ا‬
@" 0 z
" &Z‫وا-آ‬
‫او‬ 0 z ‫ا‬ ,
'7 A
5.50‫ت‬ "9A5& ‫آ‬
10gm
Hydrocortisone
1%
1-Lidocaine
‫ر‬
2-aminacrine
A highly
fluorescent anti-
infective dye used
clinically as a
topical antiseptic
and experimentally
as a mutagen,
3-ethanol
‫ة‬ / ‫دة‬ ‫آ‬ ‫م‬ 2&
M"
4-sucrose
, - & !% j‫د‬
#4 5 ?
5-saccrine
, - & !% j‫د‬
#4 5 ?
" & @")‫ن‬ 9 %-‫ا‬ 5 ‫ا‬
@"9 2 ‫ا‬ ‫ء‬ 9+‫ا‬
7‫ت‬ "9AGelDentinox
teething gel
Acyclovir
M"%‫و‬ "0 ‫ا‬ ‫دات‬ ‫ا‬ `‫أآ‬
(!z ‫م‬ 2& ،ًK "r
‫وى‬ K ‫ج‬ ‫ص‬ y
p"2' ‫ا‬ U ‫ا‬ ‫وس‬ ",
" & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2&
‫وي‬ K
P ‫ا‬ U " ‫ا‬
#6 ‫ا‬ T" =)،
5 0 ‫ا‬،M" zg|‫ا‬
M"? ‫ا‬
4.5"9ACreamAcyclovir 5%
٥٠| P a g e
Acyclovir
‫دات‬ ‫ا‬ `‫أآ‬
M"%‫و‬ "0 ‫ا‬ ،ًK "r
‫ص‬ y (!z ‫م‬ 2&
‫وس‬ ", ‫وى‬ K ‫ج‬
p"2' ‫ا‬ U ‫ا‬
" & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2&
‫وي‬ K
P ‫ا‬ U " ‫ا‬
#6 ‫ا‬ T" =)،
5 0 ‫ا‬،M" zg|‫ا‬
M"? ‫ا‬
12.5"9A‫ت‬Creamzovirax 5%
Chlorzoxaze
‫زون‬ 2‫رزوآ‬ #! ‫ا‬
Chlorzoxazone
‫ت‬ "ِy ُ @ ‫ه‬
(!" ‫وا‬ ‫ت‬ ‫ا‬
(َ َ) P ‫ا‬ P Y ‫ا‬
ً&Z‫آ‬ centrally
acting skeletal
muscle relaxants.
Paracetamol
‫ل‬ 6 ‫ا‬ $ %‫وا‬ @! 2
j‫ار‬ I# R, y‫و‬،
" & ‫ات‬ ‫ث‬ +p %
, ‫ت‬ #
z ‫ا‬ 4
Y ‫ا‬
o0 ‫ا‬ ‫ت‬
12"9A‫ت‬20
‫ت‬ 4‫آ‬
Myolgin
PEPPERMIN
T
OIL+EUCAL
YPTUS
OIL+THYME
EXT.
" & ‫ات‬ ‫ث‬ +z ‫ا‬ ‫-ت‬ I
, # ‫ا‬
‫ت‬ K
@"!0 ‫ا‬
24"9A5& ‫آ‬Relax
massage
cream
٥١| P a g e

More Related Content

What's hot

صحة الفم والأسنان
صحة الفم والأسنانصحة الفم والأسنان
صحة الفم والأسنانaskelajad
 
نصائح العناية بالأسنان
نصائح العناية بالأسناننصائح العناية بالأسنان
نصائح العناية بالأسنانmahmoud zohdi
 
SEÑORA LEY (CONJUNTO CLASICO)
SEÑORA LEY (CONJUNTO CLASICO)SEÑORA LEY (CONJUNTO CLASICO)
SEÑORA LEY (CONJUNTO CLASICO)Marcos Burbano
 
La Cuna - Piano Nota a Nota (Ray Barreto)
La Cuna - Piano Nota a Nota (Ray Barreto)La Cuna - Piano Nota a Nota (Ray Barreto)
La Cuna - Piano Nota a Nota (Ray Barreto)Marcos Burbano
 
Papo Luca Patrones Cromaticos - Libro4(demo)
Papo Luca Patrones Cromaticos - Libro4(demo)Papo Luca Patrones Cromaticos - Libro4(demo)
Papo Luca Patrones Cromaticos - Libro4(demo)Marcos Burbano
 
Basic cephalometrics
Basic cephalometricsBasic cephalometrics
Basic cephalometricsSaeed Bajafar
 
Ağız ve diş sağlığı (1)
Ağız ve diş sağlığı (1)Ağız ve diş sağlığı (1)
Ağız ve diş sağlığı (1)Irfan Türkgüler
 
AMADA MIA (CHEO FELICIANO)
AMADA MIA (CHEO FELICIANO)AMADA MIA (CHEO FELICIANO)
AMADA MIA (CHEO FELICIANO)Marcos Burbano
 
Model analysis in orthodontics /certified fixed orthodontic courses by India...
Model analysis in orthodontics  /certified fixed orthodontic courses by India...Model analysis in orthodontics  /certified fixed orthodontic courses by India...
Model analysis in orthodontics /certified fixed orthodontic courses by India...Indian dental academy
 
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامة
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامةعلاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامة
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامةashrafmostafahammam
 

What's hot (18)

صحة الفم والأسنان
صحة الفم والأسنانصحة الفم والأسنان
صحة الفم والأسنان
 
نصائح العناية بالأسنان
نصائح العناية بالأسناننصائح العناية بالأسنان
نصائح العناية بالأسنان
 
認識骨質疏鬆症 --蔡長祐
認識骨質疏鬆症 --蔡長祐認識骨質疏鬆症 --蔡長祐
認識骨質疏鬆症 --蔡長祐
 
SEÑORA LEY (CONJUNTO CLASICO)
SEÑORA LEY (CONJUNTO CLASICO)SEÑORA LEY (CONJUNTO CLASICO)
SEÑORA LEY (CONJUNTO CLASICO)
 
تسوس الأسنان
تسوس الأسنان تسوس الأسنان
تسوس الأسنان
 
La Cuna - Piano Nota a Nota (Ray Barreto)
La Cuna - Piano Nota a Nota (Ray Barreto)La Cuna - Piano Nota a Nota (Ray Barreto)
La Cuna - Piano Nota a Nota (Ray Barreto)
 
Anacaona bajo
Anacaona   bajoAnacaona   bajo
Anacaona bajo
 
Tiro ao alvaro
Tiro ao alvaroTiro ao alvaro
Tiro ao alvaro
 
Papo Luca Patrones Cromaticos - Libro4(demo)
Papo Luca Patrones Cromaticos - Libro4(demo)Papo Luca Patrones Cromaticos - Libro4(demo)
Papo Luca Patrones Cromaticos - Libro4(demo)
 
Lloraras
LlorarasLloraras
Lloraras
 
Basic cephalometrics
Basic cephalometricsBasic cephalometrics
Basic cephalometrics
 
Anacaona piano score
Anacaona   piano scoreAnacaona   piano score
Anacaona piano score
 
Book do Carnaval Sax Alto
Book do Carnaval Sax AltoBook do Carnaval Sax Alto
Book do Carnaval Sax Alto
 
Ağız ve diş sağlığı (1)
Ağız ve diş sağlığı (1)Ağız ve diş sağlığı (1)
Ağız ve diş sağlığı (1)
 
AMADA MIA (CHEO FELICIANO)
AMADA MIA (CHEO FELICIANO)AMADA MIA (CHEO FELICIANO)
AMADA MIA (CHEO FELICIANO)
 
Vassourinha - Solo V
Vassourinha - Solo VVassourinha - Solo V
Vassourinha - Solo V
 
Model analysis in orthodontics /certified fixed orthodontic courses by India...
Model analysis in orthodontics  /certified fixed orthodontic courses by India...Model analysis in orthodontics  /certified fixed orthodontic courses by India...
Model analysis in orthodontics /certified fixed orthodontic courses by India...
 
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامة
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامةعلاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامة
علاج نزيف اللثة بخطوات فعالة و بسيطة والاسباب ونصائح هامة
 

Viewers also liked

أساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانأساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانFiras Kassab
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistryHema Latha
 
أساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانأساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانFiras Kassab
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistryZirgi Rana
 
معجم مصطلحات امراض الفم و الاسنان
معجم مصطلحات امراض الفم و  الاسنانمعجم مصطلحات امراض الفم و  الاسنان
معجم مصطلحات امراض الفم و الاسنانEntesar Mohammed
 
antibiotics for dental student
antibiotics for dental studentantibiotics for dental student
antibiotics for dental studentIAU Dent
 
Dental pharmacology (1)
Dental pharmacology (1)Dental pharmacology (1)
Dental pharmacology (1)Abdullah Azim
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infectionAlka Singh
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics) Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics) Iyad Abou Rabii
 
طب اسنان بابل-المضادات الحيوية 2016
طب اسنان بابل-المضادات الحيوية 2016طب اسنان بابل-المضادات الحيوية 2016
طب اسنان بابل-المضادات الحيوية 2016Saad Jabbar
 
Antibiotics in Oral and Maxillofacial Surgery
Antibiotics in Oral and Maxillofacial SurgeryAntibiotics in Oral and Maxillofacial Surgery
Antibiotics in Oral and Maxillofacial SurgeryMohammed Haneef Farooq
 
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]Simona Belu
 
Analgesics
AnalgesicsAnalgesics
AnalgesicsAnan
 
Medications in dentistry
Medications in dentistryMedications in dentistry
Medications in dentistrydrferas2
 
Antibiotics in dentistry
Antibiotics in dentistryAntibiotics in dentistry
Antibiotics in dentistryChia Kadir
 
analgesics and dentistry
analgesics and dentistryanalgesics and dentistry
analgesics and dentistryMehul Shinde
 

Viewers also liked (20)

أساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانأساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنان
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistry
 
أساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنانأساسيات الأدوية في طب الأسنان
أساسيات الأدوية في طب الأسنان
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistry
 
drugs used in dentistry
drugs used in dentistrydrugs used in dentistry
drugs used in dentistry
 
معجم مصطلحات امراض الفم و الاسنان
معجم مصطلحات امراض الفم و  الاسنانمعجم مصطلحات امراض الفم و  الاسنان
معجم مصطلحات امراض الفم و الاسنان
 
antibiotics for dental student
antibiotics for dental studentantibiotics for dental student
antibiotics for dental student
 
Dental pharmacology (1)
Dental pharmacology (1)Dental pharmacology (1)
Dental pharmacology (1)
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infection
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics) Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
 
طب اسنان بابل-المضادات الحيوية 2016
طب اسنان بابل-المضادات الحيوية 2016طب اسنان بابل-المضادات الحيوية 2016
طب اسنان بابل-المضادات الحيوية 2016
 
Contents of the dental carpule - Pharmacology of local anesthesia
Contents of the dental carpule - Pharmacology of local anesthesiaContents of the dental carpule - Pharmacology of local anesthesia
Contents of the dental carpule - Pharmacology of local anesthesia
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Antibiotics in Oral and Maxillofacial Surgery
Antibiotics in Oral and Maxillofacial SurgeryAntibiotics in Oral and Maxillofacial Surgery
Antibiotics in Oral and Maxillofacial Surgery
 
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]
Manual of local anesthesia in dentistry, 2 e (2010) [pdf][unitedvrg]
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Medications in dentistry
Medications in dentistryMedications in dentistry
Medications in dentistry
 
Antibiotics in dentistry
Antibiotics in dentistryAntibiotics in dentistry
Antibiotics in dentistry
 
Complications of local anesthesia
Complications of local anesthesiaComplications of local anesthesia
Complications of local anesthesia
 
analgesics and dentistry
analgesics and dentistryanalgesics and dentistry
analgesics and dentistry
 

Recently uploaded

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 

Recently uploaded (20)

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 

Microsoft word الادويه المستخدمه فى طب الاسنان 5-

  • 1. ٠| P a g e
  • 2. ١| P a g e
  • 3. ٢| P a g e
  • 4. ٣| P a g e ‫آ‬ ‫ا‬‫ا‬ ‫ا‬ ‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬ benzocaine-1 )‫ر‬( benzydamine-2 hydrochl ‫ب‬ ‫د‬ cetalkonium-3 ‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬ $ %‫وا‬ & !'# ( ) * "+ ) ‫ا‬ , - ‫ى‬ ‫ا‬ ‫ت‬ & /0# ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫م‬ 2& ‫ث‬ + 4 ‫ات‬ " & / ‫ر‬ ‫و‬ 5 0 ‫ا‬ 6 27- –‫و‬ ( '* ‫ت‬ "# ‫ا‬ "4‫ا‬ 6 ‫ا‬ $ 9 ‫ب‬ -‫ا‬. *< =9& - ‫ل‬ 0? @2 ‫ا‬ ‫ر‬ '‫آ‬ ‫او‬ 9.5 ‫ت‬ "9A ‫خ‬ spray B.B.C benzocaine-1 )‫ر‬( clove oil-2 ( 07 C ‫ا‬ D &‫ز‬–/ 5 F0 ‫وح‬ # @") " & @! 2 5 - ‫ر‬ ‫و‬ ‫ن‬ 9%-‫ا‬ 1.5 ‫ت‬ "9A 5‫ه‬Dentocalm clove oil-1 (07 C ‫ا‬ D&‫ز‬–‫وح‬ # / 5 F0 geranium-2 " ‫ا‬ & ‫ا‬ & 6) lidocaine-3 )‫ر‬( @") " & 5 - @!2 ‫ن‬ 9%-‫ا‬ 3.50 ‫ت‬ "9A #I‫ل‬Clovacaine
  • 5. ٤| P a g e benzocaine-1 )‫ر‬( ( ‫آ‬١٢ K % (‫ا-آ‬ ‫ن‬ 9% ‫ر‬2‫ت‬ "9A5‫ه‬Dentocaine Jojoba oil-1 ( ) * ‫و‬ ‫ت‬ ‫د‬ ‫ع‬ 2& ‫و‬ & !' ‫ا‬ @ ‫اع‬ 7- M, - ‫وح‬ 6 ‫ا‬ ‫م‬ N ‫إ‬ P , F/# 7‫أ‬ P ‫إ‬ lidocaine-2 )‫ر‬( @") " & ‫ر‬ ‫و‬ / 5 0 ‫ا‬ 6 27-– ‫ج‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ا‬ ‫ا‬ 5 ‫ت‬ "9A gelJogel aminacrine-1 (used as a topical antiseptic) lidocaine-2 )‫ر‬( @") " & 50# / ‫ر‬ ‫و‬ 7‫ت‬ "9AgelMedijel cetalkonium-1 ‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬ ‫ى‬ ‫ا‬ $%‫وا‬ & !'# () * "+ ) ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫ا‬ , - ‫ت‬ & /0# (‫آ‬ K A ١٢K % R * 627 50# / ‫و‬ 6‫ت‬ "9A(AMundisal
  • 6.
  • 7. ٦| P a g e anthraquinone-1 glycoside ‫وب‬ !" ‫ا‬ #K C& 50 ‫ا‬ 4 C T2 ‫ا‬ lidocaine-2 )‫ر‬( salicylic acid-3 ‫ب‬ ) ‫د‬ ‫و‬ 5 @!2 ٣‫ات‬ " & $% ! # ‫وح‬ "" ‫"%ج‬" ‫و‬ ‫ا‬ 5‫ت‬ "9A‫ن‬ ‫ده‬Salivex-l anthraquinone-1 glycoside T2 ‫ا‬ ‫وب‬ !" ‫ا‬ #K C& 4 C50 ‫ا‬ menthole-2 M I_‫را‬ ‫ر‬ "? D &‫ز‬ F 0 ‫ة‬Z " M & /K ‫-ت‬ 4‫ن‬ C 4-‫ا‬ (`. salicylic acid-3 ‫ب‬ ) ‫د‬ ‫و‬ 5 @!2 @") " & $% ! # ‫وح‬ ‫%ج‬ ‫و‬ ‫ا‬ 5‫ت‬ "9A‫ن‬ ‫ده‬piravex lidocaine-1 )‫ر‬( aminoacridine-2 (used clinically as a )antiseptictopical salicylic acid-3 @!2‫د‬ ‫و‬ 5‫ب‬ @") " & $% ! # ‫وح‬ ‫%ج‬ ‫و‬ ‫ا‬ 7.5 ‫ت‬ "9A gelSeptogel
  • 8. ٧| P a g e lidocaine-1 )‫ر‬( cetyl pyredinium-2 chloride thatantisepticIt is an kills bacteria and other microorganisms Chloroceresol-3 ‫دة‬ ‫آ‬ ‫دة‬ ‫ا‬ ‫ه‬ ‫#"م‬ $ ‫ات‬ %& $ ‫ا‬ '( ‫ذاذات‬ * ' +, ‫ا‬ - " ‫ا‬ @") " & ),- ‫ر‬ .-‫و‬ 4.5 ‫ت‬ "9A gelcanyon Active Ingredients Amlexanox...............2 mg (anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores),) Inactive Ingredients Microcrystalline cellulose, Carbomer, (‫آ‬ K A ١٢K % (‫ا-آ‬ ‫م‬ 2& ‫ح‬ * ‫ج‬ 5 0 ‫ا‬ P # @ @"c ' ‫ا‬ ‫ا‬١٢ `‫آ‬d , M9 % ‫م‬ 2& -‫و‬ ( *‫أ‬ ‫ل‬ 0?e @١٢M9 % P # ‫أو‬ M K 9 ‫ذوى‬ M" "'? "g 40‫ت‬ "9A‫اص‬ *‫ا‬Alpthtabn lidocaine-1 )‫ر‬( jojoba oil-2 *It possesses microbial properties which discourage the growth of bacteria and fungal microbes *The oil also contains nutrients such as vitamin E, B complex vitamins, and minerals such as silicon, @") " & 50# / ‫ر‬ ‫و‬ 5‫ت‬ "9AgelJobadel
  • 9. ٨| P a g e 1-menthol ‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ ! F "0 5 26 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ 2- thymol = ‫ا‬ @ ‫ج‬ 2) j‫د‬ ‫د‬ ‫وه‬ / ‫آ‬ ‫م‬ 2)‫و‬ ‫ت‬ & /0# 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the teeth) Saccharine sodium-4 , #I ‫ا‬ "6 ‫ا‬ 5 / ‫ا‬ , - 50 ‫ا‬ 5- Glycerin + Deionized water. 50# T? @") " & *""" """),- ! """""""""""""""""#‫و‬ $%. *‫رب‬ """"""""""""""12 3‫ا‬ """"""""""""""" ‫ا‬ 4""""" 5 6""""" ‫ا‬ """"" ‫ا‬ """""17‫را‬ """"""""""""""""""""""""" 8 ‫ب‬ """"""""""""8 ‫ا‬ ) 9. *‫رب‬ """"""""""""""12 """"""""""""""""" 5 ‫"4%ك‬"""""""""""""""""""" ‫ا‬ 6""" """ ‫وا‬ ‫ن‬ ‫ا‬. *6"" <9 ""12 ‫ظ‬ """ !‫و‬ """9 >$ ‫ن‬ ‫ا‬. 9.75 ‫ت‬ "9A orovex chlorhexidine-1 100mHCL125mg used in disinfectants and Active substance in healing wound 9K ‫وم‬Z# ‫ا‬ ‫ث‬ + 4 ‫ات‬ " & ),- ! #‫و‬ $% 3‫ت‬ "9AHexitol
  • 10. ٩| P a g e cetrimide25%-1 ?‫د‬ -‫ا‬ ), ‫م‬ . 5 ? ),- ‫ال‬ B-fungs‫و‬microbs lidocaine-2 )6 D -‫ر‬ .-( 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the teeth) ‫ث‬ + ‫ات‬ " & *""" """),- ! """""""""""""""""#‫و‬ $% *"""""" ‫ا‬ """""" ‫ن‬ ‫وا‬ 1.30 ‫ت‬ "9A Citrolin-F 1-Povidone iodine 200mg ‫ة‬ """ - ،‫ة‬ """),- G""" 9 ‫ذات‬ ‫دة‬ """- G"" , ‫ا‬ ‫وق‬ ""1 ‫وا‬ ‫وح‬ "" ‫ا‬ " G" ‫و‬K" ‫ا‬ G"2 ‫ا‬ ‫ت‬ "! ) ‫ا‬ 3‫ا‬ """"""" ‫ا‬ )44""""""" 5)"""""""2 L4 ‫ا‬( ‫ت‬ 2 , ‫وا‬ K A j 4‫وا‬ " & *<=9& - ‫ا‬ % ‫ء‬ 9+‫ا‬ ( I ‫ا‬ ‫ب‬ ) ‫ا‬ ‫%ج‬ ‫ا‬ ‫وى‬ ‫و‬ 3.20 ‫ت‬ "9A Betadine Mw 1-menthol ‫ع‬ 9 9 ‫ا‬ D &‫ز‬ @ % %‫ا‬ ‫ن‬ ! F "0 5 26 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ clove oil-2 (07 C ‫ا‬ D&‫ز‬–‫وح‬ # / ‫د‬ ‫و‬ 5 F0 3-thymol ‫م‬ 2)‫و‬ = ‫ا‬ @ ‫ج‬ 2) j‫د‬ ‫آ‬‫ت‬ & /0# ‫د‬ ‫وه‬ / 4-glycrein 50# T? @") " & $% ! # ‫"%ج‬""""""""""""""""" ‫و‬ "" ‫ا‬ ‫وح‬ "" """ N """),-‫و‬ $%. 3.75 ‫ت‬ "9A Oracin
  • 11. ١٠| P a g e 1-menthol ‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ ! F"0 526 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ 2-methyl salisylate 0.06% 3-eucalyptol eucalyptol is used in flavorings, fragrances, and cosmetics 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the TEETH) @") " & """"" """""),- ! """""""""""""""""#‫و‬ $% 4.90 ‫ت‬ "9A oradent 1-menthol ‫ع‬ " ‫ا‬ O"2‫ز‬ B"- 6" ‫ا‬ ‫ن‬ L- Q"""" . """" ‫ا‬ 6"""" R""""D 2 ‫ن‬ ‫ا‬ clove oil-2 S"" $ ‫ا‬ O""2‫ز‬–‫وح‬ "". ""),- K3‫ا‬ ‫د‬ +-‫و‬ % Q .- 3-cinnamon ‫ت‬ """! ) ‫ا‬ """19 L- 6"""9 """ 5 2 L4 ‫وا‬ 2 , ‫ا‬ 4-methyl paraben *an anti-fungal agent often used in a variety of cosmetics and personal-care products. *It is also used as a food preservative " & j),- ! #‫و‬ $% 4.25 ‫ت‬ "9A Ora-zed
  • 12. ١١| P a g e 1-BENZYDAMINE 0.15% is a locally-acting nonsteroidal anti- inflammatory drug with local anaesthetic and analgesic properties for pain relief and anti- inflammatory treatment of inflammatory conditions of the mouth 9K ‫وم‬Z# ‫ا‬ 4٣ ‫ات‬ ),- ! #‫و‬ $% 2.5 ‫ت‬ "9A TANTUM VERDE HEXETIDINE 0.1% IT Is an anti-bacterial and anti-fungal agent commonly used in both veterinary and human medicine. It is a local anesthetic, astringent and deodorant and has antiplaque effects.[ (‫آ‬١٢ K % 50# / R *‫و‬ 627 5‫ت‬ "9AORALDENE 1-CHLOHEXIDINE used in disinfectants 2- Sodium citrate used as an acidity regulator in drinks 3- sodium borate used in biochemical and chemical laboratories to make buffers @") " & 50# / R *‫و‬ 627 14.75 ‫ت‬ "9A LYSOPLAC
  • 13. ١٢| P a g e S """""""" 2‫ود‬ ‫ا‬ """""""" -‫و‬ ! S""""""""""" U - 67 """"""""""" 3)٢ S""""""""""" 3‫إ‬ 6""""""""""" ‫آ‬ 9( ‫م‬ """"" $ -‫أ‬= )""""" -‫و‬ ! B -‫و‬ """"""""""""""""""""""""""""""""" ‫ا‬(((( ، ‫ل‬ """"" - ، ‫ل‬ 4 """""‫آ‬ 2 S"""""#Z! ، ‫ى‬ """"" U2‫إ‬ O"""""2‫ز‬ G""""" L - ‫ت‬ """"" ‫آ‬.... ‫ص‬ """""# S""""" ‫اغ‬ """""] ‫1%ب‬ """"""""""""""""""""""""""""""" ^.... ‫اص‬ """""""#‫أ‬‫1%ب‬ """"""" ^ """)!٠`٥""" -‫و‬ ! """ - 6"""""""""" 2 B -‫و‬ """""""""" ‫ا‬ B -‫و‬ """""""" ‫ا‬ """""""" -‫و‬ ! ‫ت‬ """4‫آ‬ - G""" - 6""" ‫إ‬ G""""""" ! ‫ا‬ ‫م‬ """"""" $ -b‫ا‬ G ‫ا‬ G 2 c.... G ‫ا‬ *1 2 ‫ادورال‬ ! 6c . ‫ا‬ ‫ء‬ de ‫ا‬ ‫ا‬ N.Q , c ‫و‬ +2‫أ‬ ‫ل‬ cb‫ا‬ 1 2.... 67 # ‫ا‬ ‫ام‬ . ^ *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ ، - 2 ‫ات‬ -‫اب‬i2 ‫ا‬ 69 j,4!.... ‫ت‬ 1 ‫ا‬ 69 ‫ام‬ . ^ % 9 ‫وى‬ ! G! k ‫ا‬:::: *‫وا‬ ‫ص‬ # 1 2 B 6 ‫إ‬ G S‫آ‬ )6k#‫أ‬ 1!٨‫اص‬ #‫أ‬ ‫م‬ ‫ا‬ 69 ‫1%ب‬ ^((((.... m 1 ‫وا‬ ),- ‫م‬ . 2 ‫أ‬ 2 n ‫ذ‬ R-‫و‬ ‫ر‬ )d ‫ا‬ ‫ء‬ 3‫أ‬ ‫ادورال‬ ! ‫إ‬ S 1 ‫ا‬ B- 6 ‫و‬b‫ا‬ G3%U ‫ا‬ G2 )# ‫ب‬ 4 b.... ) N3.75‫اص‬ #‫أ‬ 14TABS ‫1%ب‬ ‫ا‬ BradoralBradoralBradoralBradoral 1-lysozym 10mg 2-dequalinium 25mg *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ ‫اب‬i2 ، - 2 ‫ات‬ - ‫ا‬ 69 j,4! m 1 ‫وا‬ ),-) N‫ت‬ 9‫اص‬ #‫أ‬ 20TABS ‫1%ب‬ ‫ا‬ laryprolaryprolaryprolarypro
  • 14. ١٣| P a g e 1-dichlorobenzyl alchol ,antisepticmild able to kill andbacteria associatedviruses with mouth and .infectionsthroat 2-amylmetacresol antiseptican used to treat ofinfections mouththe throatand *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ 2 ‫ات‬ -‫اب‬i2 ، - ‫ا‬ 69 j,4! ‫ب‬ """"""""""") o ‫ول‬b‫ا‬ S""""""""""" ‫ة‬ 1 ‫وا‬ m 1 ‫ا‬ ‫ات‬p""""""" ‫ا‬:*‫اص‬ """""""#‫أ‬ """"""""""""""2 L4 ‫دة‬ """"""""""""""+- ‫ة‬ 1 ‫ة‬ ),- *""""" ),5 6""""" """"" 5 """"""""""""""""> 5‫و‬ Q""""""""""""""""$b‫ا‬ r ‫ا‬ *‫ة‬ """""""""""),- ‫اص‬ """""""""""#‫أ‬ G"""""""""""""" ‫وإزا‬ ‫ة‬ """""""""""""" 1 """"""""""""""""""" ‫ا‬ ‫ب‬ """"""""""""""""""") ‫إ‬ ‫ة‬ 1 ‫وا‬ ) N‫ت‬ 22‫اص‬ #‫أ‬ 20TABS ‫1%ب‬ ‫ا‬ StrepsilsStrepsilsStrepsilsStrepsils
  • 15. ١٤| P a g e
  • 16. ١٥| P a g e Nicomethanole hydroflouride A I ‫ا‬ T24 #K‫ن‬ ‫ا‬ S 511.50‫ت‬ "9AToothpast e ‫ن‬ 9%‫ا‬ ‫ن‬ 6 ‫ن‬ 9% % 2I ‫ا‬ EGYFLUOR gel,paste Many flour N 1 ‫ا‬ 6‫ن‬ ‫ا‬ S 521‫ت‬ "9AToothpast e ‫ن‬ 9%‫ا‬ ‫ن‬ 6 ‫ن‬ 9 % % 2I ‫ا‬ Sensodyne 100gm 12‫ت‬ "9A Sensodyne 55gm
  • 17. ١٦| P a g e
  • 18. ١٧| P a g e Vit C- 2 ? ‫وا‬ ? -, `# ‫ا‬ Im #K ‫ظ‬ 0I# `# ‫ا‬ F&Z7 4 @& !) "# K , K 2& 9 ‫ا‬ ‫ء‬ +‫ا‬ ‫ن‬ 9%-‫ا‬ 8.00‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS amovit-c 1000 Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C) ‫ن‬ 9%-‫ا‬ @& !) "# K 4.00‫ت‬ "9A‫اص‬ #‫أ‬ 20TABSCevarol 500mg Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C) ‫ن‬ 9%-‫ا‬ @& !) "# K ‫ـ‬ ، ‫ا‬ ‫ج‬ ‫إ‬ ‫ي‬ ‫ا‬ ‫و‬ ‫وا‬ ‫ن‬ !‫ا‬ " # $ % #& ،‫م‬ %( ‫ا‬ ،$) ‫ا‬ ،‫ن‬ *+,‫ا‬ 12.00 ‫ت‬ "9A ‫ار‬ 9Vitacid-c1g
  • 19. ١٨| P a g e
  • 20. ١٩| P a g e chymotrypsin + trypsin ‫م‬p$ L ‫ا‬ ‫ه‬‫ت‬ 2p$‫ا‬ proteolytic ‫ت‬ 5‫و‬ 4 ‫ا‬ L ! )$‫ا‬ m2 c B ‫ال‬ K 3Z ! exudative phaseB- inflamation - 5 Sk1 49 Speptidic chainsK !‫و‬ ‫ن‬ L ‫ه‬ t 9 inflamation ‫ص‬ #٣- 2 ‫ات‬ - )G ! S‫آ‬b‫ا‬ S4#( B-‫و‬‫دة‬ 2‫ز‬ BL ‫ا‬ G 1 ‫ا‬ G ‫ا‬ ١-‫ن‬ ‫ا‬ R w ! ٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٤-‫ا‬ N ‫اى‬ ! ‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9 ‫ن‬ ‫ا‬ 15‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS Ambezim-g chymotrypsin + trypsin ‫ص‬ #٣- 2 ‫ات‬ - )G ! S‫آ‬b‫ا‬ S4#( BL ‫ا‬ B-‫و‬‫دة‬ 2‫ز‬ G 1 ‫ا‬ G ‫ا‬ ١-‫ن‬ ‫ا‬ R w ! ٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٤-‫ا‬ N ‫اى‬ ! ‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9 ‫ن‬ ‫ا‬ 20‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS Alphintern
  • 21. ٢٠| P a g e chymotrypsin + trypsin 1 ---- 2222- 2 G 4-‫أ‬ B 1 ‫ا‬ m2 c B 6 .5 ‫ان‬ 6 ‫إ‬ 6 + ‫ا‬ G D ‫ا‬ ‫اض‬ b‫ا‬.... ••••‫ت‬ 1 ‫ا‬ 69 G -p ‫ا‬:١-٢6 ‫إ‬ ٣4 ‫أ‬ ‫ات‬ -.... ‫ت‬ 69 G- G k! # ‫ى‬i ‫ا‬ 6 D ‫ا‬ ‫رم‬ ‫ا‬ G ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ 6 2 18‫ت‬ "9A5‫او‬ B ‫ت‬ 4-‫ا‬ Alpha Chymotrypsin 1-THIOTEX ACID 300MG o" ‫آ‬ "` R 4 ١_B2 L5 p 12 )S-k ‫ا‬ B2 L5( S ] 5 B- B 12 n i ‫ب‬ k ‫ا‬ 2-B- B 12 B $ ‫ا‬ B2 L5 B2 L5 m2 c R ‫ا‬ ‫%و‬)‫اوآ‬ B N‫و‬( DOSE : in severe cases 300-600 mg. - by iv. Injection daily for two to four weeks, after that oral tablets should be used as 300 mg daily as a maintenance dose. *I ‫ا‬ , ‫اص‬ *-‫ا‬ j 4‫وا‬ j &‫د‬ ‫ا‬ ‫ر‬ /0 ‫ا‬ pC, ‫ب‬ =K-‫ا‬ ‫ب‬ ‫ا‬26‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS THIOTEX 300MG 30‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS THIOTEX 600MG
  • 22. ٢١| P a g e
  • 23. ٢٢| P a g e ‫آ‬ ‫ا‬‫ا‬ ‫ا‬‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬ 1-metronidazol & !'# ‫دة‬ M"_‫ا‬ ‫ه‬ ‫ا‬ *One of the antibiotic that kill bacteria by in hibition of nuclic acid OF BACTERIA 30*" ‫آ‬ S"L - S""""""" , ‫ا‬ ‫وزن‬ B""""""- *K"""" !S"""" c """" """$‫وز‬ G """ ? """ ١٠"""""42 5 """"" ‫آ‬. *K""""""""""""""""""""""" 42٣٠ K""""9 G!‫و‬ """"+-١٠ ‫وي‬ "" 2٣٠٠"" - """""""""""""""""""""""""""""""""" - 2. *‫اب‬ """"d ‫ا‬ p"""" ‫آ‬ 5‫و‬ ١٢٥S""""L """" -٥ S"""""""""""""""""""""""""""""""""""""""-: *S"‫آ‬ ‫أذا‬5"! K" - ٥"""""""""""""""""""""""""""""""" - ‫ازول‬ """"""""""""" $‫و‬ -. *‫م‬ . """""""" 2 ‫أذا‬١٢ B""""""- """""" - 2 S""""""- S"""""""""""""""""""""""""""""" N%9. *‫أي‬٤S-٣‫ات‬ - - 2 *‫ن‬ 9%-‫ا‬ ‫وي‬ K)‫أذا‬ & !' ‫وي‬ K D7 ‫آ‬ M"_‫ا‬ ‫-ه‬( *M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬ & !' ‫ا‬ T'2 M"_‫ا‬ ‫ه‬ ‫ا‬. 6‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flagyl 500mg .505 ‫ت‬ "9A‫اص‬ *‫أ‬ 20 TABS Flagyl 250mg 04.5 ‫ت‬ "9A ‫اب‬ rFlagyl 125mg *U07 T"‫آ‬ ‫ا‬ F 2 ‫ا‬ K 6 ‫ا‬ U07 ) C 2 ‫ا‬ *‫وي‬ K‫ن‬ 9%-‫ا‬)‫أذا‬ & !' ‫وي‬ K D7 ‫آ‬ M"_‫ا‬ ‫-ه‬( *M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬ & !' ‫ا‬ T'2 M"_‫ا‬ ‫ه‬ ‫ا‬. 2.90"9A‫اص‬ *‫أ‬ 20 Flagicure forte 500mg 1.60 "9A ‫اص‬ *‫أ‬ 20 TABS Flagicure 250mg
  • 24. ٢٣| P a g e 1-amoxycillin 2-flucloxacillin ‫ن‬ & "4 ‫دان‬ ‫ه‬ ‫ا‬s‫وه‬"#K , p"# ‫ا‬ ‫ج‬ K , " K ‫ت‬ ‫و‬ !" ‫وى‬ ‫ا‬ ' 2 ‫وا‬ 'A ‫ا‬ ‫ام‬ 6 ‫ا‬ c'= ‫ا‬. *@"##"% 2‫آ‬ #‫آ‬ #0 ‫ا‬ flucloxacillin)( ‫ى‬ * "+ ) j‫ز‬ 0 ‫ا‬ ‫ت‬ ‫و‬ !" ‫ا‬ 5&Z7-Z"9"##"29 penicillinase *‫ل‬ 0? ‫و‬ ‫ر‬ '!# ‫ق‬ ,١٨K 2'‫آ‬500mg (‫آ‬٦-٨‫او‬ ‫ت‬ K % ‫ص‬ *1g(‫آ‬١٢ j r T24 K % ‫وى‬ ‫ا‬ *4 ‫ل‬ 0?-‫ا‬١٠ ‫ات‬ 9%١٢٥56- ٢٥٠(‫آ‬ (٨ ‫ت‬ K % *‫ن‬ 9%-‫ا‬ ‫وي‬ K 50 ‫وا‬)'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *‫وح‬ 6 ‫ا‬ ‫ث‬ #) M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 7.5 ‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flumox 250 mg 18‫ت‬ "9A 20 TABS ‫اص‬ *‫ا‬ Flumox 500 mg 24‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flumox 1G 13‫ت‬ "9A‫اب‬ rFlumox 100 ( T"‫آ‬ ‫ا‬ U07K 6 ‫ا‬ U07*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬ )'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *‫وح‬ 6 ‫ا‬ ‫ث‬ #) M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 6‫ت‬ ) NFlumox 1G
  • 25. ٢٤| P a g e @"##"2"2‫آ‬ ‫أ‬ "%‫أ‬ o"9" ", ‫.وآ‬ @ @"##"2"2‫آ‬ v‫ا‬ 7‫أ‬ ‫وف‬ ‫ا‬ ‫ت‬ 6 ‫ض‬ & ‫ن‬ !, ‫م‬ ‫-آ‬ "' ‫ا‬ ‫د‬ A‫و‬ ‫وي‬ ‫ا‬ @ ‫دة‬‫ر‬ C) M , ‫ع‬ 9 ‫ا‬ ‫ا‬s‫ه‬ 4‫د‬ P#K ‫وم‬ C ‫ا‬ & !' ‫ا‬ @ j‫ود‬ @"##29'# ‫ن‬ !"‫ه‬ "%‫أ‬ o"9" ", ! ‫.ا‬ Clavulinic acid ‫ر‬ 4L ‫اص‬ #b‫:ا‬ 625 ١٠٠٠(‫آ‬ 56 ١٢‫ة‬ MK %٧‫م‬ &‫أ‬ M# ‫آ‬ *‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬ )'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *6 ‫ا‬ ‫ث‬ #)‫وح‬ M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 58‫ت‬ "9A‫اص‬ *‫أ‬ 14TAB S Augmentin1g 35‫ت‬ "9A‫اص‬ *‫أ‬ 10TAB S Augmentin625 mg 375‫ت‬ "9A‫اص‬ *‫أ‬ 10TAB S Augmentin375 mg 11.5‫ت‬ "9A9C4 Augmentin600 mg T"‫آ‬ ‫ا‬ U07‫ل‬ c{ ‫اب‬ d ‫ا‬: B-١-٦‫ات‬: 50*@ 56 Z"‫آ‬ )@"##2"2‫آ‬ -‫ا‬ P#K M 2C 56‫آ‬ (! M+ + ‫أو‬ @" K A. *7‫وز‬ (0? P9 ١٢y & 56‫آ‬٤( Z"‫آ‬ ) @٣١٢M+ + " & ‫ات‬. B- K ‫أ‬٦‫ات‬: 5*‫ات‬ M+ + ( Z"‫آ‬ ) @ " & ٤٥٧ ‫ام‬ %-‫ا‬ U0728‫ت‬ "9A‫اب‬ r Augmentin312 mg/5ml 37‫ت‬ "9A‫اب‬ r Augmentin457 mg/5ml
  • 26. ٢٥| P a g e T"‫آ‬ ) U07 ‫ال‬ Augmenti n ‫ر‬ '!# ‫اص‬ *v‫*ا‬ 625 mg (‫آ‬١٢j٧‫م‬ &‫ا‬ *(‫آ‬ ‫او‬١٢K %١‫ام‬ A j & z ‫ا‬ ‫وى‬ ‫ا‬ 4 , ‫ب‬ *‫ن‬ 9%-‫ا‬ ‫وي‬ K 50 ‫وا‬)& !' ‫ا‬ ‫ام‬ 6 ‫ا‬ 'A ‫ام‬ 6 ‫ا‬ ' %‫و‬ & !' ‫وا‬ "_‫ا‬ ‫ه‬ ‫ا‬( *‫ث‬ #)‫وح‬ 6 ‫ا‬ M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ *6) 9 ‫ا‬ ‫ت‬ -‫ا‬ & !' ‫ا‬ @K)T ‫ا‬ `# ‫ا‬( 25‫ت‬ "9A‫اص‬ *‫أ‬ 8 TABS Hibiotic 1g 26‫ت‬ "9A‫اص‬ *‫أ‬ 10 TABS Hibiotic 625mg 19‫ت‬ "9A‫اص‬ *‫أ‬ 10 TABS Hibiotic 375mg U07 T"‫آ‬ ‫ا‬ B-١-٦‫ات‬ 50@ 56Z"‫آ‬ ) 56‫آ‬ (! @"##2"2‫آ‬ -‫ا‬ ‫أو‬ @" K A P#K M 2C M+ +. 7‫وز‬ (0? P9١٢56‫آ‬ y &٤Z"‫آ‬ ) @ (٣٢٠ ٣" & ‫ات‬ B- K ‫أ‬٦‫ات‬: 5(٣@ " & ‫ات‬ Z"‫آ‬ )٤٦٠. @ '‫أآ‬ (0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫اذا‬ ٤٠‫ر‬ '! ‫ا‬ MK A syd& 56‫آ‬ ‫ام‬ %-‫ا‬ U07‫ت‬ "9A23‫اب‬ rHibiotic 460mg ‫ت‬ "9A32‫اب‬ rHibiotic 460mg
  • 27. ٢٦| P a g e ‫ز‬p1- ‫ص‬ # S‫آ‬ 6 ‫ى‬ 12 B ‫آ‬ -‫أ‬ ‫رات‬ ‫ه‬ ‫اى‬ 5 ‫آ‬ ‫آ‬ 9‫و‬ ‫م‬ 2‫د‬ ] B ‫رات‬ ‫ه‬ $ - ‫دل‬ 2: -B ‫آ‬ -‫أ‬ 500- ‫آ‬ ‫آ‬ 9 B2500- B e 4 ‫ا‬ *(‫آ‬ ‫ص‬ *٨@! &‫و‬ ‫ت‬ K % (‫آ‬ / & ‫ان‬٦, ‫ت‬ K % j & z ‫ا‬ m-‫ا‬ 4 B B- ‫ل‬ c% ‫ا‬ ١٦-٨ *(‫آ‬ ‫ص‬ * F=7 / &٨ / & ‫ان‬ @! &‫و‬ ‫ت‬ K % (‫آ‬ ‫ص‬ * F=7٦‫ت‬ K % `‫ا-آ‬ m-‫ا‬ 4 , j‫ر‬ /y ١-‫ن‬ ‫ا‬ ‫اج‬ w ٢-U ‫ا‬ ‫ب‬ ) ‫ا‬ ٣-‫وى‬ ‫ا‬ 2 L4 ‫ا‬ ‫ت‬ "9A 20‫اص‬ *‫أ‬ 10 TABSFloxamo 1 M"#K , 5A "2‫دروآ‬ 0"% ‫ل‬ ‫ج‬ ‫دة‬ ‫ا‬ MK 6 ‫ا‬ ‫ب‬ ‫ا‬50 ‫ا‬ 627‫وا‬ ‫ن‬ 9%-‫وا‬ ‫ه‬١‫ة‬ 4‫وا‬ MK 6‫آ‬ ‫ام‬ A #K M 2C ‫او‬ ‫م‬ " ‫ا‬ , ‫ة‬ @" &‫و‬ 2 @" K A١٠ (*-‫ا‬ #K ‫م‬ &‫ا‬ *‫وى‬ ‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ "9A 8‫اص‬ *‫أ‬ 8 TABS Curisafe
  • 28. ٢٧| P a g e Amoxycillin as 250mg, 500mg and 1000mg injections. ‫وى‬ ‫ا‬ 69 2 L4 ‫ا‬ *G 4‫آ‬٥٠٠- S‫آ‬٨‫ت‬ *B 4‫آ‬٥٠٠ S‫آ‬ -١٢G 2 # ‫ا‬ 69 ‫م‬ . 5 *9C4١‫ر‬ '!# ‫ام‬ A *9C4500‫ام‬ 6 ‫ل‬ 0? (for mor information visit this web) http://www.me dsafe.govt.nz/pr ofs/datasheet/i/i biamoxinj.pdf *prevent blood infection due to procedures such as dental extractions in patients who are at risk of developing endocarditi s *S4# ‫م‬ . 5 ‫ن‬ ‫ا‬ R w B- 2 # endocarditi s 6D - 69 6 1 ‫ا‬ -p5 -‫و‬ ‫ا‬ & !' ‫ا‬ ‫وى‬ ‫ا‬ * "9A 3.70‫اص‬ *‫أ‬ 12 TABS IBIAMOX25 0 mg "9A 8.00‫اص‬ *‫أ‬ 12 TABS IBIAMOX50 0 mg
  • 29. ٢٨| P a g e
  • 30. ٢٩| P a g e @" `" ‫و‬ ) ‫رو-ك‬ "‫آ‬٣٠ 56 Ketorolac tromethamin ‫م‬p $ L ‫وا‬ ‫اص‬ . ‫:ا‬ ‫-ك‬ "‫آ‬MK 6 P ‫إ‬ P 9& "g ‫ت‬ |‫ا‬ ‫دات‬ M&‫ود‬ " 2 ‫ا‬ NSAIDs o s ‫و‬ P &Z7‫إ‬ p"'`) P#K (" & , ‫ز‬ 9"6"2‫اوآ‬ #!"%١‫و‬٢ (COX-1+COX-2) ‫ق‬ ?-‫ا‬ P#K ‫اه‬ *‫ا‬ ' &‫.و‬ B 1 ‫ا‬ N O15 B e 4٦٠-: ‫-ك‬ "‫آ‬@") @C4 P=*‫ا‬ I " &٤ C4‫ة‬ ‫و‬ " & @ ‫ي‬ =* ‫ام‬ %‫إ‬٥&‫أ‬‫م‬ ‫ال‬ ‫ق‬ 9٦٠-: ‫-ك‬ "‫آ‬ ‫ل‬ ' ‫أ‬ F=7 I " & @") P=*‫أ‬٤" & @C4 ‫ي‬ =* ‫ام‬ %‫إ‬ ‫ة‬ ‫و‬ ٥pC, ‫م‬ &‫أ‬ ‫ى‬ # BL - ‫ن‬ ‫وا‬ ‫ا‬ "9A 10‫اص‬ *‫أ‬ 20 TABS Ketolac 10 "9A5 @C4Ketolac ‫م‬ 5 ! ‫ك‬ 9 L2‫.د‬ Diclofenac Potassium 25-50@ 56 (‫آ‬ ‫ص‬ *‫أ‬ ‫م‬ , ‫آ‬٨ ‫ت‬ K %. ‫ول‬ ! |k 2‫و‬ ! ‫اص‬ #‫أ‬ ‫9%م‬ ‫آ‬ ? 3Z ‫ت‬ 4N ‫ا‬ ‫ة‬ ‫ا‬ K. -‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ GU ‫وا‬. "9A 5‫اص‬ *‫أ‬ 10TABCata lam50mg 9"9A‫اص‬ *‫أ‬ 10 TABS Cata lam25mg ‫ي‬ I) M'#K A & P#K٣‫-ت‬ ' ‫أ‬ P#K ‫ي‬ I) M'#K‫و‬٦ % ‫-ت‬ ' ‫أ‬ 9 (‫آ‬ P, M ' -‫ا‬ ٤}٧M ' e "9A. @C4Cataflam75mg
  • 31. ٣٠| P a g e ‫ك‬ 9 L2‫د‬ ‫م‬ 5 !. Diclofenac Potassium B e 4 ‫ا‬: ‫أو9%م‬ ‫ل‬ ‫إ‬ 2٥٠ ‫اص‬ #‫أ‬٣‫ات‬ -- 2 G2 # ‫ت‬ 4N ‫ا‬ ! ‫ة‬ ‫ا‬ K ? 3Z5 B-. O15 ‫ل‬ c{١٢ -: ‫أو9%م‬ ‫ل‬ ‫إ‬ 2٢٥ Kk#‫ا‬ 1! ‫اص‬ #‫أ‬٣ - 2 ‫ات‬ -. ‫أو9%م‬ ‫ام‬ . ‫أ‬ R 2 ‫ل‬ c{ - 5 ‫اص‬ #‫أ‬ O15٩2‫و‬ ‫ات‬ ‫ع‬ #‫أ‬ ‫ام‬ . ‫إ‬ B ‫دو‬ ‫أو‬ B2‫ر‬ 9 - !.. -GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬"9A 5.5‫أ‬‫اص‬ * 10TAB Oflam 50 "9A 3.5 ‫اص‬ *‫أ‬ 10TAB Oflam25 ‫م‬ "% ) ‫ك‬ 9", #!&‫د‬ – Diclofenac Potassium. B e 4 ٧٥-١٥٠, 56 j 4‫وا‬ K 6‫آ‬ ‫م‬ " ‫ا‬ #K 2C ‫او‬ ‫ت‬ K A K @ ‫ل‬ 0?-‫ا‬)١- ١٢(9%١-٣56 #K 2C ‫م‬ " ‫ا‬ , ‫ت‬ K A -‫ن‬ 9%-‫ا‬ $#y -‫-ت‬ 4 , ‫ح‬ z)‫وا-ر‬ ‫ب‬ -‫ا‬ ‫ت‬ "# ‫ا‬ 5 ~ ‫ا‬ M"4‫ا‬ 6 ‫ا‬ 6"9A‫اص‬ *‫أ‬ 20TAB Dolphin K25 mg 8"9A‫اص‬ *‫أ‬ 20TAB Dolphin K50 mg 6.5"9A102'‫آ‬Dolphin K75 mg 6.75"9A3@C4Dolphin K75 mg/3m
  • 32. ٣١| P a g e B 9‫و‬ ! ‫آ‬ Ketoprofen*M 2'‫آ‬٣‫ات‬ (‫ا-آ‬)٥٠•( *( K M9C4" & *MC #٣‫ات‬ ١-‫ت‬ ‫د‬ ٢-‫-م‬ @!2 ٣-‫-ت‬ 4 , K 2 F7-‫ا‬ ‫ت‬ ‫ا‬ ‫ة‬ 69I ‫وا‬ ‫وا-ذن‬ ‫ن‬ 9%-‫ا‬ ‫ب‬ ‫وا‬ 1.75 "9A‫اص‬ *‫أ‬ 10TAB Ketolgin 25mg 2 "9A‫اص‬ *‫أ‬ 10TAB Ketolgin50m g 8 "9A10 2'‫آ‬Ketolgin 200mg 3 "9A3 @C4Ketolgin100 mg B 9‫و‬ ! ‫آ‬ Ketoprofen *M 2'‫آ‬٣‫ات‬ (‫ا-آ‬)٥٠•( *( K M9C4" & -GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬3.753.753.753.75) N‫اص‬ *‫أ‬ 10TAB Ketofan 25mg 5555‫ت‬ ) N20 2'‫آ‬Ketofan 50mg 5555‫ت‬ ) N10 2'‫آ‬Ketofan 75mg 3333‫ت‬ ) N3@C4Ketofan 100mg G """"""""""" 4‫آ‬ S"""""""""""‫آ‬ ‫ى‬ """" 15 G"""" 5% N 6""""""""":::: 200200200200"""""" - ‫اب‬i- B 9‫و‬ ! 42‫ا‬ 1- 2@K M 2'‫آ‬ ( ‫آ‬ 5 0 ‫ا‬ S & ?٤- ٦9K ‫أو‬ ‫ت‬ K % ‫وم‬Z# ‫ا‬. @! 2 @" 0" ‫را‬ ‫€-م‬ $& % ‫ل‬ , R, y‫و‬ ‫د‬ ‫و‬ ‫ارة‬ I# ‫ت‬ - 3.503.503.503.50) N‫اص‬ *‫أ‬ 10TAB Rapifen200 mg
  • 33. ٣٢| P a g e 1-paracetamol 350mg 2-ibuprofen 200mg B e 4 ‫ات‬ - ‫3%ث‬ ‫ص‬ # - 2 ‫ل‬ c% ‫"%ث‬""3 ‫ص‬ """# Q"""k$ - 2 ‫ات‬ - GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬2.752.752.752.75) N‫اص‬ *‫أ‬ 20TAB Megafen ibuprofen-1‫ر‬ """""""""4L:S"""""""""+ 2 """"" ! ?i"""""w‫ا‬‫م‬ """"" , ‫ا‬ 6"""" ?‫ر‬ """"3‫ا‬ S"""" G""""""" N‫و‬ ? """"""" ‫ا‬ ‫ر‬ """""4L٤٠٠""""" - ‫ت‬ O S‫آ‬ ‫ل‬ c%:S+ 2 K‫وه‬ # G N ٢٠٠O S‫آ‬ - ‫ت‬ ‫3""""""""%ث‬ ‫اب‬ """"""""€ ‫او‬ - 2 ‫ات‬ - GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ B L ‫ا‬ Sk - ‫م‬ ‫ا‬ 6.756.756.756.75) N‫اص‬ *‫أ‬ 20TAB Brufen200 mg 13.5013.5013.5013.50) N‫اص‬ *‫أ‬ 20TAB Brufen400 mg 15151515) N‫اص‬ *‫أ‬ 20TAB Brufen600 mg 6666) N‫اب‬ rBrufen100 mg /150ml
  • 34. ٣٣| P a g e ‫ك‬ 9 L2‫د‬ ‫م‬ 2‫د‬ ] ‫ر‬ """""""4L ‫ا‬:٧٥-١٥٠ ‫م‬ " ‫ا‬ P , 5 c#، ‫او‬ ‫ة‬ 4‫وا‬ M K 6 M K‫ز‬ ‫و‬ M 2C ‫م‬ " ‫ا‬ ‫ل‬ y. ‫ل‬ c ‫ا‬:٣(! •# S& ? @K ‫م‬ " ‫ا‬ P, 56‫آ‬ #K M 2C 50 ‫ا‬٢-٤ ً" & ‫ات‬. ‫ل‬ `:(0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫إذا‬ ٣٠/ & 56‫آ‬٦٠‫إ‬ ٩٠#K M 2C •#٢- ٤P & ‫ات‬ -‫ل‬ o‫ا‬ 6 ‫دوا‬ -‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ GU ‫وا‬. 11.2511.2511.2511.25) N‫اص‬ *‫أ‬ 30TAB Voltaren 25 11.9011.9011.9011.90) N‫اص‬ *‫أ‬ 20TAB Voltaren 50 28) N‫اص‬ *‫أ‬ 10sr TAB Voltaren- sr 100 12.75) N3@C4Voltaren 75 Ibuprofen‫ر‬ """4L ‫ا‬:‫واء‬ ‫ا‬ s y‫أ‬ M &‫و‬ y ‫ة‬ P #K ( ,‫أ‬ P / & ‫إن‬ ‫و‬ ‫ص‬ = ‫أ‬ ( 0 ‫ا‬ @ ‫ن‬ ‫آ‬ ‫م‬ / ‫ا‬ $ js y‫أ‬ ‫ر‬ ‫ا‬ j "+d ) ( "#C ‫ة‬ ‫ا‬ P#K. P / &٤٠٠5 6 D % ‫أو‬ $ ‫أر‬ ( ‫آ‬ ‫ت‬ K %. ‫ا‬s ‫ه‬ ‫َم‬ 2ُ& ‫ج‬ ُ‫ء‬‫…وا‬ ‫ا‬ ‫ب‬ ‫ا‬( ِm 0 ‫ا‬ B """""""L ‫ا‬ S"""""""k ‫آ‬ """"""" ‫ا‬ Q""""""" . ‫و‬ S] ‫ا‬ K9. 4) N‫اص‬ *‫أ‬ 10sr TAB Ibuprofen 400mg Tabs
  • 35. ٣٤| P a g e Mefenamic acid٥٠٠‫ام‬ N S-٣ - 2 ‫ات‬ -. *T4 = ‫ا‬ 5 v‫ا‬ ‫ب‬ -‫ا‬ ‫أو‬ ‫رم‬ # ‫ت‬ m|‫ا‬ $ ' & ‫ي‬s ‫ا‬ ‫أو‬ M" ‫ا‬ M"4‫ا‬ 6 ‫ا‬. ‫ت‬ ‫إ‬0 ‫ا‬(m -*‫ارة‬ I# R, y. 5.50) N‫اص‬ *‫أ‬ 10 TAB Mefenam 500mg Lornicam*@ ‫ص‬ * $ #'& ‫م‬ !"7‫ر‬٨5 6 M & % ‫اص‬ *‫ا‬ " ‫آ‬ $ @ ‫و‬s ‫ا‬ @ ' % 9 (_‫ا‬ 2 ‫ا‬. *‫ول‬ 9) 5 & , ‫اص‬ *-‫ا‬ ‫ت‬ K A@ ٨T 6& -‫و‬ 5 6 I ‫ا‬ / ) ‫ح‬ 2 ‫ا‬ =*-‫ا‬ ‫ت‬ K 6 ‫ا‬ @ ‫وه‬١٦" & 56 p') ‫ا‬ 5 -‫ا‬ ‫ب‬‫رج‬ y ( m 0 ‫ا‬‫ج‬ ‫و‬ 5 -‫ا‬ ‫اض‬ K‫ا‬ , ‫ب‬ -‫وا‬ ‫ب‬ -‫ا‬ ‫-ت‬ 4 Y ‫ا‬ ‫ب‬ ‫وا‬ # =0 ‫ا‬ ( =0 ‫ا‬ 7‫ا‬ + ‫ا‬. 13.00) N‫اص‬ *‫أ‬ 10 TAB Lornicam Rapid tablets
  • 36. ٣٥| P a g e
  • 37. oral gel Daktarin oral gel Miconaz 2% oral gel Micoban 2% - 2 ‫ات‬ - ‫3%ث‬*‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 18‫ت‬ "9A - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4,70‫ت‬ "9A - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4,90‫ت‬ "9A ٣٦| P a g e Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬ Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬ Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬
  • 38. ٣٧| P a g e Nystatin mechanism NYSTATIN bind to sterols in the fungal cell membrane... RESULTING IN disturbances in cell membrane function as selective barrier ,THIS LEADS TO loss of essential cellular constituents - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 3.50"9AOral drops Nystatin 30 ml Nystatin S 2 ‫ا‬ ‫م‬Z7 !" ‫ا‬ U07 .‫آ‬٨‫ت‬ 0/٦ & ‫ا‬ 3$4 ‫ت‬ 0 $ ‫ا‬ ‫او‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4‫ت‬ "9AOral drops Fungistatin 30ml Nystatin r $‫م‬p$ L ‫ا‬ m! ‫ا‬ .‫آ‬٨‫ت‬ 0/٦ & ‫ا‬ 3$4 ‫ت‬ 0 $ ‫ا‬ ‫او‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4‫ت‬ "9AOral drops MYCOSTATI N 30 ml
  • 39. ٣٨| P a g e
  • 40. ٣٩| P a g e Calcium glubionate 1200mg5ml - 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 5‫ت‬ "9A ‫اب‬ rHi-cal 100ml Calcium- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 5‫ت‬ "9A ‫اب‬ rGolden cal 100ml Calcium" & j 4‫وا‬ j•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 7.50‫ت‬ "9A‫اب‬ rCalci cal
  • 41. ٤٠| P a g e Calcium carbonate 500mg Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 ‫ن‬ ‫ا‬2 # 3‫ت‬ "9A12 cap - 2'‫آ‬ ‫ت‬ Calcimate 500 500mg of calcium Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 2 # ‫ن‬ ‫ا‬ 6‫ت‬ "9A‫اص‬ *‫أ‬ 10 TAB Bone-cal *Calcium carbonate =700mg *calcium 180mg Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 2 # ‫ن‬ ‫ا‬ 15‫ت‬ "9A‫اص‬ *‫أ‬ 30 TAB marcal
  • 42. ٤١| P a g e
  • 43. ٤٢| P a g e Cod liver oil ‫ت‬ I ‫ا‬ '‫آ‬ D& 1cap _ 1-2times daily _‫ا‬s g ( ! ‫ر‬ = ' & ‫د‬ @" "0 @" ",»‫د‬« #K K 2& T" % ) =9K P , ‫م‬ " 2 ! ‫ا‬ ‫م‬ Y ‫ا‬ ‫ن‬ 9%v‫وا‬ 22‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 120 cap Seven seas Cod liver oil +vit a.d3.c 1 cap _ 1- 2times daily U 07 0"‰ ‫ا‬ C 2 ‫ا‬ 29‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 cap Ultranyl Cod liver oilAdult 1 cap _ 1-2times daily U 07 0"‰ ‫ا‬ C 2 ‫ا‬ 28‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 capCod liver oil
  • 44. ٤٣| P a g e Cod liver oil 100mg Adult 1cap _ 1- 2times daily _‫ا‬s g ( ! ‫ر‬ = ' & ‫د‬ @" "0 @" ",»‫د‬« #K K 2& T" % ) =9K P , ‫م‬ " 2 ! ‫ا‬ ‫م‬ Y ‫ا‬ ‫ن‬ 9%v‫وا‬ 14,90‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 cap Fort sea vitA,c,d,omega 3,EPA.DHA 2.5:5ml.2-3 times daily according to kids edge 0"‰ ‫ا‬ U 07 C 2 ‫ا‬ 14,90‫ت‬ "9A120ml. ‫اب‬ r High sea 120ml Vit.A4600i.u Vit D380i.u C52mg 2.5:5ml.2-3 times daily according to kids edge 0"‰ ‫ا‬ U 07 C 2 ‫ا‬ 13,90‫ت‬ "9A120ml ‫اب‬ r Halorang 120ml
  • 45. ٤٤| P a g e
  • 46. ٤٥| P a g e Lidocaine hcl 40mg MK 6: ‫"%ج‬"""""""""" 6"""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 8‫ت‬ "9ASPRA Y ‫خ‬ LIDO SPRAY Lidocaine 10%MK 6: 6"""""""""""9‫"%ج‬"""""""""" ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# ١٠‫ت‬ "9ASPRA Y ‫خ‬ Lidocaine SPRAY Lidocaine 5%MK A: ‫"%ج‬"""""""""" 6"""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 2.40‫ت‬ "9A5‫ه‬LIDOSINE
  • 47. ٤٦| P a g e Lidocaine 2%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ S 2 ‫ا‬ U073‫ت‬ "9AGelLIGNOCAINE Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ‫ن‬ 9 %-‫ا‬( '* ‫او‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 10‫ت‬ "9ASPRA Y ‫خ‬ LIGNOCAINE
  • 48. ٤٧| P a g e Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ Š# ‫ا‬@ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 10‫ت‬ "9ASPRA Y ‫خ‬ LIGNORAL Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 44.75‫ت‬ "9ASPRA Y ‫خ‬ Xylocaine
  • 49. ٤٨| P a g e
  • 50. ٤٩| P a g e Hydrocortisone ‫ات‬ &‫و‬ 2 ‫ا‬ @ ‫ه‬ ( & ‫وه‬ & zC ‫ا‬ $9 ‫او‬ R0y #K 6 %-‫ا‬ @ & ‫ا‬ S& ? @K ‫ت‬ ‫ز‬ 6 ‫ا‬ , "c ‫ا‬ K 9 ‫ا‬ " & @"), !I ‫ا‬ @" 0 z " &Z‫وا-آ‬ ‫او‬ 0 z ‫ا‬ , '7 A 5.50‫ت‬ "9A5& ‫آ‬ 10gm Hydrocortisone 1% 1-Lidocaine ‫ر‬ 2-aminacrine A highly fluorescent anti- infective dye used clinically as a topical antiseptic and experimentally as a mutagen, 3-ethanol ‫ة‬ / ‫دة‬ ‫آ‬ ‫م‬ 2& M" 4-sucrose , - & !% j‫د‬ #4 5 ? 5-saccrine , - & !% j‫د‬ #4 5 ? " & @")‫ن‬ 9 %-‫ا‬ 5 ‫ا‬ @"9 2 ‫ا‬ ‫ء‬ 9+‫ا‬ 7‫ت‬ "9AGelDentinox teething gel Acyclovir M"%‫و‬ "0 ‫ا‬ ‫دات‬ ‫ا‬ `‫أآ‬ (!z ‫م‬ 2& ،ًK "r ‫وى‬ K ‫ج‬ ‫ص‬ y p"2' ‫ا‬ U ‫ا‬ ‫وس‬ ", " & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2& ‫وي‬ K P ‫ا‬ U " ‫ا‬ #6 ‫ا‬ T" =)، 5 0 ‫ا‬،M" zg|‫ا‬ M"? ‫ا‬ 4.5"9ACreamAcyclovir 5%
  • 51. ٥٠| P a g e Acyclovir ‫دات‬ ‫ا‬ `‫أآ‬ M"%‫و‬ "0 ‫ا‬ ،ًK "r ‫ص‬ y (!z ‫م‬ 2& ‫وس‬ ", ‫وى‬ K ‫ج‬ p"2' ‫ا‬ U ‫ا‬ " & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2& ‫وي‬ K P ‫ا‬ U " ‫ا‬ #6 ‫ا‬ T" =)، 5 0 ‫ا‬،M" zg|‫ا‬ M"? ‫ا‬ 12.5"9A‫ت‬Creamzovirax 5% Chlorzoxaze ‫زون‬ 2‫رزوآ‬ #! ‫ا‬ Chlorzoxazone ‫ت‬ "ِy ُ @ ‫ه‬ (!" ‫وا‬ ‫ت‬ ‫ا‬ (َ َ) P ‫ا‬ P Y ‫ا‬ ً&Z‫آ‬ centrally acting skeletal muscle relaxants. Paracetamol ‫ل‬ 6 ‫ا‬ $ %‫وا‬ @! 2 j‫ار‬ I# R, y‫و‬، " & ‫ات‬ ‫ث‬ +p % , ‫ت‬ # z ‫ا‬ 4 Y ‫ا‬ o0 ‫ا‬ ‫ت‬ 12"9A‫ت‬20 ‫ت‬ 4‫آ‬ Myolgin PEPPERMIN T OIL+EUCAL YPTUS OIL+THYME EXT. " & ‫ات‬ ‫ث‬ +z ‫ا‬ ‫-ت‬ I , # ‫ا‬ ‫ت‬ K @"!0 ‫ا‬ 24"9A5& ‫آ‬Relax massage cream
  • 52. ٥١| P a g e